Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Dana-Farber Cancer Institute
Read disclaimer about translations

Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.

  • Find a Doctor
  • Give Now
  • My Dana-Farber
  • Close Search
  • Menu
  • COVID-19 Facts and Resources
  • For Patients and Families
  • For Physicians
  • Our Research
  • About Us
  • Find a Doctor
  • Appointments & Second Opinions
  • How You Can Help
close navigation panel

COVID-19 Facts and Resources

  • For Our Patients
  • Vaccine
  • Virtual Visits
  • For Caregivers
  • For Physicians
  • Our Research
close navigation panel

For Patients and Families

  • Why Dana-Farber
  • Care & Treatment
  • Becoming a Patient
  • Caring for a Loved One
  • Prevention & Risk
  • For Survivors
  • Clinical Trials
  • Insurance & Financial Information
  • My Dana-Farber
  • Events Calendar
  • Health Library
close navigation panel

For Physicians

  • Refer a Patient
  • Education & Training
  • Clinical Resources
  • Clinical Advances
  • Physician Gateway
close navigation panel

Our Research

  • Clinical Trials
  • Departments, Centers, & Labs
  • Innovations
  • Featured Research
  • Our Researchers
  • Core Facilities
  • Search Cancer Types
close navigation panel

About Us

  • Locations
  • Directions
  • Careers
  • Newsroom and Publications
  • Leadership
  • Community Outreach
  • Awards
  • History
  • Clinical Trials
  • Insurance & Financial Information
  • Insight Blog
  • Events Calendar
  • Health Library
close navigation panel

Appointments & Second Opinions

  • Online Second Opinion Program
  • International Patients
close navigation panel

How You Can Help

  • Ways to Give
  • Events
  • Get Involved
  • Shop
  • Give Now
  • COVID-19 Facts and Resources
    • back
    • COVID-19 Facts and Resources
    • For Our Patients
    • Vaccine
    • Virtual Visits
    • For Caregivers
    • For Physicians
    • Our Research
  • For Patients and Families
    • back
    • For Patients and Families
    • Why Dana-Farber
    • Care & Treatment
    • Becoming a Patient
    • Caring for a Loved One
    • Prevention & Risk
    • For Survivors
    • Clinical Trials
    • Insurance & Financial Information
    • My Dana-Farber
    • Events Calendar
    • Health Library
  • For Physicians
    • back
    • For Physicians
    • Refer a Patient
    • Education & Training
    • Clinical Resources
    • Clinical Advances
    • Physician Gateway
  • Our Research
    • back
    • Our Research
    • Clinical Trials
    • Departments, Centers, & Labs
    • Innovations
    • Featured Research
    • Our Researchers
    • Core Facilities
    • Search Cancer Types
  • About Us
    • back
    • About Us
    • Locations
    • Directions
    • Careers
    • Newsroom and Publications
    • Leadership
    • Community Outreach
    • Awards
    • History
    • Clinical Trials
    • Insurance & Financial Information
    • Insight Blog
    • Events Calendar
    • Health Library
  • Find a Doctor
  • Appointments & Second Opinions
    • back
    • Appointments & Second Opinions
    • Online Second Opinion Program
    • International Patients
  • How You Can Help
    • back
    • How You Can Help
    • Ways to Give
    • Events
    • Get Involved
    • Shop
    • Give Now
  • Give Now
  • My Dana-Farber
  • Read disclaimer about translations
    Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.

  • About Us
    • Awards & Honors
    • Careers at Dana-Farber
      • Communication Internships
      • IT Jobs
      • Jobs at Satellite Centers
      • Research Nursing Jobs
      • Workforce Development
        • Adult Development Program
        • Community Engagement
        • Contact Us
        • Student Training Program
    • Collaborations
    • Community Outreach
      • Community Health Needs Assessment Reporting
      • Determination of Need Community Health Initiative Funding
      • Expert Cancer Care for the Community
      • HPV and Related Cancers Outreach Program
      • Mammography Suite at Whittier
      • Mammography Van
        • Contact Us
        • FAQ
        • Sites Served
        • Van Calendar
        • Van Fact Sheet
      • Sun Safety Skin Cancer Prevention
      • Tobacco Control and Lung Cancer Prevention
    • Dana-Farber Direct Connect
    • Dana-Farber's New Visual Identity
    • Directions
      • Driving Directions from Dana-Farber
      • Driving Directions to Dana-Farber
      • Maps of Dana-Farber
      • Parking
      • Public Transportation
    • Events Calendar
    • History and Milestones
      • Advances
      • AIDS Research Program
      • In Tribute Richard A Smith
      • Milestones
      • Sidney Farber, MD
    • Leadership
      • Laurie Glimcher
    • Locations
      • Dana-Farber Brigham and Womens Cancer Center at Milford Regional Medical Center
        • Clinical Services
        • Contact Us
        • Physician Team
        • Refer a Patient
        • Support Services
      • Dana-Farber Brigham and Womens Cancer Center in clinical affiliation with South Shore Hospital
        • Clinical Care
        • Contact Us
        • Physician Team
        • Support Services
      • Dana-Farber Cancer Institute - Chestnut Hill
        • Art at Dana-Farber Cancer Institute - Chestnut Hill
        • Contact Us
        • Physician Team
      • Dana-Farber Cancer Institute - Foxborough
      • Dana-Farber Cancer Institute - Merrimack Valley
        • Espanol
      • Dana-Farber Cancer Institute at St Elizabeths Medical Center
        • Clinical Care
        • Contact Us
        • Physician Team
        • Referrals
      • Dana-Farber New Hampshire Oncology-Hematology
        • Contact Us
        • FAQ
        • Physicians
        • Referrals
        • Resources
        • Services
        • Support Groups
      • Yawkey Center for Cancer Care
        • Audio Art Tour
          • Online Audio Art Tour
        • New Art Acquisitions and Hidden Treasures
          • Assimilation
          • Basquet Ball
          • Big Bambu
          • Carmen Imperial
          • Conductor Composer
          • Five Blues
          • Forever For Old Lady Sally
          • From There to Here
          • Glysteri
          • In Between Colors
          • Incarnate
          • Landscape 30 9
          • Lapis Waters
          • Le Bouquet Rouge
          • Light Pond and the secret garden
          • Moon Fruit
          • My Neighbors Garden
          • Open Cube in Color on Color
          • Sow Melon
          • Tectonic Trace #5
          • Thread Leaf Maple in Winter
          • Vermeer and Vija Celmins
          • Visual Impressions I
          • Wavehill Dogwood
          • Wrap
        • Yawkey Center Videos
    • Mission and Values
    • Partners and Affiliates
    • Tobacco Use Policy
  • Accreditations
  • Appointments and Second Opinions
    • Online Second Opinion Program
      • After Your Online Second Opinion
      • Cost
      • FAQ
      • Get Started
  • Contact Us
  • COVID-19 Facts and Resources
    • Coronavirus COVID-19 Informacion - Espanol
      • Cita Virtual
      • Vacuna contra COVID-19 para pacientes
      • Vacunas para pacientes y sobrevivientes de cancer
    • COVID-19 Information for Caregivers
    • COVID-19 Information for Our Patients
      • COVID-19 Resources for Patients
      • Treating Your Cancer Keeping You Safe
    • COVID-19 Information for Physicians
    • COVID-19 Research at Dana-Farber
    • COVID-19 Vaccine for Patients
    • Hero Behind the Mask
    • Telehealth at Dana-Farber
  • Error
  • Find a Doctor
    • For Patients and Families
      • Becoming a Patient
        • Insurance & Financial Information
        • International Patients
          • Chinese
            • Cancer Specialists
              • Blood Cancer and Blood Disorders
              • Brain and Spinal Cancer
              • Breast Cancer
              • CAR T-Cell Therapy
              • Find a Doctor
                • Andrew Aguirre
                • Ann Partridge
                • Anna Muriel
                • Beth Overmoyer
                • Brian Wolpin
                • Bruce Johnson
                • Christopher Recklitis
                • Christopher Sweeney
                • Colleen Feltmate
                • David Barbie
                • David Jackman
                • David Kwiatkowski
                • Eliezer Van Allen
                • Elizabeth Mittendorf
                • Eric P Winer
                • Eric Zhou
                • Geoffrey Oxnard
                • Heather Parsons
                • Ian Krop
                • Ilana Braun
                • Jacob Sands
                • James Tulsky
                • Jeffrey Meyerhardt
                • Jennifer Bellon
                • Jennifer Chan
                • Jennifer Ligibel
                • Joanne Wolfe
                • Joseph Jacobson
                • Joyce Liu
                • Judy Garber
                • Kathleen Lee
                • Kenneth Kehl
                • Kimmie Ng
                • Lauren Harshman
                • Mark Pomerantz
                • Mary Ellen Taplin
                • Matthew Vander Heiden
                • Matthew Yurgelun
                • Michael Cheng
                • Nancy Lin
                • Osama Rahma
                • Panagiotis (Panos) A. Konstantinopoulos
                • Pasi Jänne
                • Rachel Freedman
                • Raphael Bueno
                • Ross Berkowitz
                • Scott Swanson
                • Stephanie Tung
                • Tari King
                • Toni Choueiri
                • Ursula Matulonis
                • Vincent Ho
                • Wendy Chen
                • William Hahn
                • William Kaelin
                • William Pirl
                • Xiao Wei
              • Gastrointestinal Cancer
              • Genitourinary Cancer
              • Gynecologic Cancer
              • Head and Neck Cancer
              • Immuno-Oncology
              • Integrative Therapies and Healthy Living
              • Lung Cancer
              • Psychosocial Oncology and Palliative Care
              • Sarcoma Center
              • Skin Cancer
              • Stem Cell Transplant Program
              • Tumor Profile Study
            • Inspiration
              • “真的很离奇”：丹娜—法伯癌症研究所William G. Kaelin博士获2019年诺贝尔医学奖感言
              • “类器官” 助力癌症药物的甄选organoid
              • 10个妙招助您控制癌症相关的压力和焦虑Stress and Anxiety
              • 2010年代最重要的癌症研究进展cancer research advances in 2010s
              • 2018资料手册 2018 Fact Book
              • 2岁肝母细胞瘤患儿痊愈后父母倍感欣慰hepatoblastoma pediatric patient story
              • Breast Cancer Patient Relocates from China for Treatment
              • CAR T-细胞临床试验帮助多发性骨髓瘤患者恢复健康
              • CDK46抑制剂如何阻碍乳腺癌生长？cdk46 for breast cancer
              • PARP抑制剂药物或称为某些卵巢癌患者随访治疗的部分标准PARP follow up therapy
              • William G. Kaelin Jr.博士在《华盛顿邮报》上发表文章：《关于用“登月”策略治疗癌症的问题》cancer moonshot
              • X光会诱发癌症吗？can x-ray cause cancer
              • 一个乳腺癌肿块是什么感觉- Brest-Lump-Feel-Like
              • 一阵持续的咳嗽是一种癌症症状吗？Persistent Cough
              • 临床试验为子宫内膜癌治疗开辟新路径endometrial cancer new trials
              • 临床试验如何推动癌症疗法的进步Clinical Trials
              • 丹娜—法伯开展用疫苗埋植剂驯化针对黑色素瘤的免疫反应的治疗Vaccine Implants against melanoma
              • 丹娜—法伯波士顿儿童医院癌症与血液疾病中心儿童期癌症幸存者的故事：深中肯綮的保肢手术limb salvage surgery for pedi patient
              • 丹娜—法伯癌症康复患者与主治医师的终生友谊patient and physician lifelong friendship
              • 丹娜—法伯癌症研究所专家专访：寻找胰腺癌治疗的新途径new avenues pancreatic cancer
              • 丹娜—法伯癌症研究所味享∙食客系列：亚洲风味椰子鸡汤Asian Chicken and Coconut Soup
              • 丹娜—法伯癌症研究所味享∙食客系列：南瓜汤Pumpkin soup
              • 丹娜—法伯癌症研究所味享∙食客系列：南瓜雪梨华夫饼Pumpkin Pear Waffles
              • 丹娜—法伯癌症研究所味享∙食客系列：地中海风金枪鱼沙拉Mediterranean Tuna Salad
              • 丹娜—法伯癌症研究所味享∙食客系列：奶油南瓜布丁creamy pumpkin pudding
              • 丹娜—法伯癌症研究所味享∙食客系列：姜末牛油果鲜虾饭Ginger, Avocado, Shrimp Bowl
              • 丹娜—法伯癌症研究所味享∙食客系列：意式迷迭香蔬菜煎蛋Rosemary and Veggie Frittata
              • 丹娜—法伯癌症研究所味享∙食客系列：核桃酥脆鳟鱼片Walnut Crusted Trout Fillets
              • 丹娜—法伯癌症研究所味享∙食客系列：燕麦能量点心Oatmeal Energy Bites
              • 丹娜—法伯癌症研究所味享∙食客系列：绿茶果昔green tea smoothies
              • 丹娜—法伯癌症研究所味享∙食客系列：胡萝卜姜汤佐香辣虾Carrot Ginger Soup with Spicy Shrimp
              • 丹娜—法伯癌症研究所味享∙食客系列：蓝莓果昔Blueberry Smoothie
              • 丹娜—法伯癌症研究所味享∙食客系列：蔬菜鹰嘴豆沙拉hummus veggie salad
              • 丹娜—法伯癌症研究所味享∙食客系列：西葫芦面包Zucchini Bread
              • 丹娜—法伯癌症研究所味享∙食客系列：西蓝花沙拉Broccoli Salad
              • 丹娜—法伯癌症研究所味享∙食客系列：超级食物版寿司Super Food Sushi
              • 丹娜—法伯癌症研究所味享∙食客系列：香料蛋白薄饼Spice Protein Pancakes
              • 丹娜—法伯癌症研究所干细胞移植患者及其妻子为医务工作者提供患者康复之旅的洞察SCT roadmap
              • 丹娜—法伯癌症研究所护士热爱护理工作的原因Nurse
              • 丹娜—法伯癌症研究所科学家识别出驱动自然杀伤细胞活动的途径pathway NK cells
              • 丹娜—法伯癌症研究所脑肿瘤患者因免疫疗法而重获新生brain tumor kept at bay by immunotherapy
              • 丹娜—法伯癌症研究所董事长兼首席执行官在《波士顿环球报》上发表评论文章：《终结烟草触及我们的魔爪》Dr. Glimcher Op-ed
              • 丹娜—法伯研究团队为罕见血液癌症——母细胞性浆细胞样树突细胞肿瘤（BPDCN）开辟新疗法
              • 为什么我应该做结肠镜检查？Getting Colonoscopy
              • 为什么胰腺癌如此难治？ Why is Pancreatic Cancer So Difficult to Treat?
              • 为何化疗往往伴有副作用？chemotherapy and side effects
              • 乳房肿块 Breast Lumps
              • 乳糖不耐受症和结直肠癌的关联Lactose Intolerance and Colorectal Cancer
              • 乳腺癌和口服避孕药有何关联？Breast Cancer and Birth Control Pills
              • 乳腺癌患者康复后重回她热爱的冰场breast cancer and skate
              • 乳腺癌患者需要多少剂量的放疗？radiation and breast cancer
              • 乳腺癌易感基因（BRCA）和卵巢癌的关联BRCA ovarian cancer
              • 乳腺癌易感基因2号（BRCA2）与胰腺癌：有何关联？BRCA2 & Pancreatic cancer
              • 乳腺癌的阶段有哪些？What Are The Stages of Breast Cancer?
              • 乳腺癌风险因素：区分事实与虚构信息的小窍门 breast cancer risk factors
              • 了解前列腺特异性抗原（PSA）数值
              • 人类乳头状瘤病毒（HPV）与头颈癌症的关联
              • 人类乳头状瘤病毒（HPV）与癌症的关系（2019年）HPV and Cancer 2019
              • 什么是乳房钙化？它会导致乳腺癌吗？Breast Calcifications
              • 什么是力量训练？它能帮助癌症患者吗？strength training for cancer patients
              • 什么是口腔癌？oral cancer
              • 什么是基因组检测（genomic testing）?
              • 什么是套细胞淋巴瘤？该如何治疗它？mantle cell lymphoma
              • 什么是意义未明的克隆性造血（CHIP）？
              • 什么是放射免疫疗法？ Radioimmunotherapy
              • 什么是结肠息肉，它们会增加结肠癌的风险吗？- polyps and colorectal cancer
              • 什么是肾癌？What is kidney cancer
              • 什么是胆道癌？Biliary Cancer
              • 什么是脑转移瘤？该如何治疗？Brain Metastasis
              • 从复发到康复：淋巴瘤患者在丹娜—法伯癌症研究所经CAR T-细胞治疗后战胜癌症lymphoma patient
              • 从患者变为员工：患者重回丹娜—法伯癌症研究所的故事From Patient to Employee
              • 何为JUUL电子香烟？
              • 何为均衡膳食？Balanced diet
              • 何为基因突变？What is a Gene Mutation?
              • 何为尤文肉瘤？What is Ewing Sarcoma
              • 何为新辅助化学疗法？neoadjuvant chemotherapy
              • 何为癌前状态？precancerous condition
              • 何为维尔姆斯瘤？该如何治疗？Wilms tumor
              • 何为肺占位体？space-occupying lesions
              • 何为肾细胞癌？该如何治疗它？renal cell carcinoma
              • 何为脂肪肉瘤？What is Liposarcoma?
              • 何为针对乳腺癌的卵巢抑制术？Ovarian suppression for breast cancer
              • 何为针对遗传性癌症症候群的级联测试？Cascade Testing
              • 何为高级别或低级别脑肿瘤的划分界限？ high- and low-grade brain tumor
              • 何时能判断体重减轻是癌症的一种表征？weight loss and cancer
              • 侵袭性乳腺癌无法阻挡年轻妈妈前进的步伐Aggressive Breast Cancer
              • 倘若我患有食道癌，我该吃哪些食物？what to eat for patients with esophageal cancer
              • 值得接种：疫苗不会致癌vaccines and cancer
              • 健康生活的一剂良药：合理膳食和坚持运动对癌症患者大有裨益Diet and Exercise
              • 儿童白血病治疗的新进展（至2019年8月）advances in pediatric leukemia
              • 儿童肾脏肿瘤的表征与症状pediatric kidney tumors
              • 免疫疗法：定义、作用机制及当前的研究（至2019年7月）Immunotherapy: What It Is, How It Works, and Current Research
              • 免疫疗法与乳腺癌的新进展What’s New in Immunotherapy and Breast Cancer?
              • 免疫疗法可以帮助到小细胞肺癌患者吗？ Immunotherapy and Lung Cancer
              • 免疫疗法如何治疗淋巴瘤Immunotherapy to Treat Lymphoma
              • 免疫疗法如何用于治疗结直肠癌？Immunotherapy on Colorectal Cancer
              • 免疫疗法对肺癌的正确治疗时机Immunotherapy and lung cancer
              • 关于头颈癌症的5个必知事项 5 things head and neck
              • 关于姑息疗法的10个必知事项10 facts about palliative care
              • 关于宫颈癌筛查的五个必知事项cervical cancer screenings
              • 关于巴雷特食管的五个事实Barrett’s Esophagus
              • 关于怀孕与乳腺癌：必知事项-Pregnancy and Breast Cancer
              • 关于戒烟：可行与不可行的办法 quit smoking
              • 关于抗血管生成食物的科学解密Anti-Angiogenic Foods
              • 关于新型冠状病毒（COVID-19）的必知事项
              • 关于睾丸癌您不知道的五件事-5 things you did not know about testicular cancer
              • 关于罕见癌症患者寻求专家诊疗的建议rare cancer
              • 关于肺癌：非吸烟人士需要了解的五个事项non smokers
              • 关于胶质母细胞瘤的5个必知事项5 things about glioblastomas
              • 关于薄荷香烟的4个常见问答menthol cigarettes
              • 关于青年女性患乳腺癌的十个须知Young Women with Breast Cancer
              • 关于麻醉：种类、副作用及其它必知信息Anesthesia
              • 关于黑色素瘤和皮肤癌的真相 Truth About Melanoma
              • 前列腺特异性抗原水平（PSA）升高是否意味着我患有前列腺癌？elevated PSA
              • 化疗药物会在患者体内停留多久？chemo in body
              • 华裔非霍奇金淋巴瘤患者在丹娜—法伯获得治愈希望yan cheng patient story NHL
              • 卵巢癌：请牢记这7个术语seven terms for ovarian cancer
              • 卵巢癌与免疫疗法：科研的进展Ovarian Cancer and Immunotherapy
              • 吸烟如何诱发肺癌？ Cigarettes and Lung Cancer
              • 咖啡会对结肠癌风险或幸存率有影响吗？coffee and colon cancer
              • 咖啡会诱发癌症吗？coffee and cancer risk
              • 咽喉癌有哪些症状和表征？throat cancer symptoms
              • 咽喉癌的基础事实 throat cancer facts
              • 哪些国家拥有最高和最低的患癌率？ Country Cancer Rates
              • 哪些患者需要在早期乳腺癌治疗后进行化疗？Chemo after Early Breast Cancer Treatment
              • 哪些职业与患癌风险有关？professions and cancer risks
              • 哪类癌症与获得性免疫缺乏综合征（艾滋病）有关？AIDS-Related Cancers
              • 在人的一生中，为何男性比女性患癌的可能性更高？Men More Likely Than Women to Develop Cancer
              • 在对抗癌症方面，免疫疗法可以和化学疗法结合吗？chemo-immuno combination agaisnt cancer
              • 在放疗后，我为什么经常感到疲惫？fatigue and radiation
              • 在日光中保护皮肤的五个妙招5 tips for skin protection in the sun
              • 坚果和结肠癌：有什么关联？ Nuts and Colon Cancer
              • 增强免疫治疗：使“冷”肿瘤变“热”的竞赛Make “Cold” Tumors “Hot”
              • 夜晚进食会影响癌症风险吗？Eating Late at Night
              • 夜间盗汗和癌症的关系是什么？ Night Sweats and Cancer
              • 大豆和乳腺癌有关联吗？Soy and breast cancer
              • 如何告诉别人我患癌的事实？tell someone you have cancer
              • 如何应对儿童因治疗引起的恶心？Child’s Treatment-Related Nausea
              • 如何应对癌症治疗期间出现的恶心和食欲减退问题？nausea and loss of appetite
              • 如何找到合适的癌症互助小组？Cancer Support Group
              • 如何正确洗手？proper handwashing
              • 如何用手术治疗妇科癌症？gyn cancer surgeries
              • 如何降低患结直肠癌的风险？Reduce My Risk of Colorectal Cancer
              • 妇科癌症免疫疗法的最新信息Immunotherapy for Gynecologic Cancers
              • 妇科癌症免疫疗法的最新进展immunotherapy gynecology
              • 妇科癌症筛查：必知事项（至2019年7月）gynecologic cancer screening
              • 子宫内膜异位症与子宫内膜癌有哪些区别？endometrosis differences
              • 子宫内膜癌有哪些症状？symptoms of endometrial cancer
              • 宫颈癌免疫疗法的新临床试验New Clinical Trials Test Immunotherapy for Cervical Cancer
              • 家用癌症基因检测：必知事项At-Home Genetic Tests
              • 对于儿童癌症患者而言，何为介入性放射学？interventional radiology
              • 对抗失眠的小妙招Tips for Managing Insomnia
              • 对癌症患者而言，天然气泡矿泉水是一种健康饮品吗？Seltzer Water
              • 对话丹娜—法伯癌症研究所2019年度诺贝尔奖得主William G. Kaelin Jr.博士：八问八答8Questions with Dr. Kaelin
              • 小细胞肺癌和非小细胞肺癌的区别是什么？ Small cell lung cancer and NSCLC
              • 尤文肉瘤有哪些表征和症状？Symptoms of Ewing Sarcoma
              • 尼古丁会诱发癌症吗？Nicotine
              • 应对肺癌偏见上的建议 Lung Cancer Stigma
              • 引发细胞产生致癌性的原因 cancerous cell
              • 影像焦虑？试试这5个妙招 Reducing Scanxiety
              • 成人和儿童脑肿瘤的区别differences between pediatric and adult brain tumors
              • 成年患癌和儿童患癌的区别是什么？adult and children's cancers
              • 我体内携带乳腺癌易感基因1号及2号（BRCA12）——该怎么办？
              • 抑郁症与癌症：必知事项depression and cancer
              • 接触无线局域网（Wi-Fi）会致癌吗？Wifi and cancer
              • 携手廿余载，丹娜—法伯癌症研究所科研护士与爱人再回首当年在病房的求婚仪式proposal
              • 放疗是如何帮助治疗转移性乳腺癌的？-Radiation-Therapy-Metastatic-Breast-Cancer
              • 新化合物在防御HIV-1病毒方面展现希望novel compounds HIV
              • 新近确诊卵巢癌病例的标准疗法进入新时代newly diagnosed ovarian cancer new era
              • 无线头戴式耳机会引发癌症吗？wireless headphone and cancer
              • 晨型人与乳腺癌患病风险morning person and breask cancer risk
              • 曾经患癌会加剧其它癌症的患病风险吗？Second cancer
              • 最常见于成人的白血病类型most common leukemias in adults
              • 最适合乳腺癌患者的瑜伽动作yoga poses for breast cancer patients
              • 有哪些因素可致使癌症扩散？What Causes Cancer to Spread?
              • 机器人如何改善头颈癌症的治疗？robotics surgery for head and neck
              • 杏仁能抗癌吗？apricot seeds and cancer
              • 林奇综合症基因检测的新在线工具New Online Tool Lynch Syndrome
              • 止痛药物和癌症：必知事项pain medications and cancer
              • 沙利度胺药物揭示在癌症治疗中以无成药性转录因子为靶点的通路Thalidomide and undruggable transciption factors
              • 烤焦的食物会引发癌症吗？burnt food and cancer
              • 焦虑或抑郁是癌症的表征吗？Anxiety Depression and Cancer
              • 生酮饮食和癌症:患者必知事项Ketogenic Diets
              • 甲状腺癌肿块给人以何种感觉？thryoid lump
              • 电子烟健康风险最新信息：至2019年11月 vaping and health risks
              • 电子香烟与癌症的关联E-Cigarettes and Cancer
              • 画笔陪她度过疗程和恢复期paints
              • 瘙痒是癌症的征兆吗 Itching and Cancer
              • 癌症与假日：庆祝和应对的窍门cancer and holidays
              • 癌症与氧气的关联cancer and oxygen
              • 癌症会让患者掉发吗？cancer and hair loss
              • 癌症和肿瘤的区别Cancer and a Tumor
              • 癌症和酒精 Cancer and Alcohol
              • 癌症对睡眠的影响cancer and sleep
              • 癌症的精准医学和免疫治疗: 必知事项Precision Medicine and Immunotherapy
              • 癌症等级和癌症分类的区别grade and stage of cancer
              • 白血病有哪些症状？Symptoms of Leukemia
              • 皮肤癌早发现的方法：ABCDE法则for early skin cancer detection
              • 睾丸癌的临床表现和症状有哪些？ Signs of Testicular Cancer
              • 研究发现聚腺苷二磷酸核糖聚合酶抑制剂药物（PARP Inhibitor Drug）耐药性的来源resistance
              • 研究发现诸多癌细胞中脆弱性包膜的诱因fragile envelope
              • 碳酸饮料会引发癌症吗？Does Soda Cause Cancer?
              • 社会工作者如何帮助癌症患者？social workers
              • 神经母细胞瘤具有遗传性吗？Neuroblastoma
              • 科学家如何探索免疫疗法的更多益处?Expand the Benefits of Immunotherapy
              • 科学研究如何推动头颈癌症的治疗？research and head and neck
              • 科学研究帮助淋巴瘤患者顺利展开干细胞移植治疗Lymphoma patient stem cell transplant
              • 究竟什么是肿瘤？What is a Tumor, Exactly?
              • 紫外线A段（UVA）和紫外线B段（UVB）的区别
              • 给刚确诊癌症的患者们的5条建议5 Tips for Patients Recently Diagnosed with Cancer
              • 给癌症患者的10个运动小贴士10 Exercise Tips for Cancer Patients
              • 给肺癌患者的小贴士：避免事项Tips for Lung Cancer Patients
              • 给转移性乳腺癌患者的生活小贴士Tips for Living with Metastatic Breast Cancer
              • 综合性疗法是如何帮助肺癌患者的？Integrative Therapies
              • 老年女性乳腺癌患者的应对建议tips for older breast cancer patients
              • 肝癌的表征和症状-Signs and Symptoms of Liver Cancer
              • 肠道细菌和癌症有何关联？Gut Microbes and Cancer
              • 肥胖症会诱发癌症吗？obesity and cancer
              • 肺癌与空气污染相关吗？lung cancer and air pollution
              • 肺癌有哪些征兆和症状?Signs and Symptoms of Lung Cancer
              • 肺癌精准医疗的十周年纪念Precision Medicine for Lung Cancer Marks Tenth Anniversary
              • 肿瘤学护理实习生手札：《我对护理工作的热忱》oncology nursing
              • 胃癌有哪些症状？stomach cancer signs
              • 胃肠道癌症的治疗在近期都有哪些进步？recent advances in GI cancer treatment
              • 胆囊有哪些功能？Gallbladder
              • 背痛和癌症相关吗？back pain and cancer
              • 胰腺癌具有遗传性吗？Can Pancreatic Cancer Be Inherited?
              • 胰腺癌患者故事：从胰腺癌防御机制上的一处弱点入手Pancreatic cancer patient FOLFIRINOX
              • 胰腺癌有哪些征兆和症状？Pancreatic Cancer
              • 胶质母细胞瘤患者确诊7年后的故事glioblastoma patient CB
              • 脑肿瘤有哪些常见症状？common brain tumor symptoms
              • 脖子上的肿块是癌症的体征吗？lunp in the neck
              • 膀胱癌有哪些症状？Symptoms of Bladder Cancer?
              • 良性前列腺增生（BPH）会引发前列腺癌吗？
              • 若我患有妇科癌症，我还可以生育子女吗？fertility for gynecologic cancer
              • 茶叶与预防癌症：有何关联？Tea and Cancer
              • 解密癌症姑息疗法Palliative Care for Cancer Patients
              • 解密癌症护理团队各类护士的职责Nurses
              • 解读病理学报告Understanding Your Pathology Report
              • 该如何准备与肿瘤医师的网络诊疗？Prepare for a virtual visit
              • 诱发癌症的6个常见迷思6myths causing cancer
              • 诺奖研究让肾癌患者受益nobel prize and kidney cancer patient
              • 谁应当接受免疫疗法？Who Should Be Treated with Immunotherapy?
              • 贫血症和癌症的关系Anemia and Cancer
              • 运动对转移性结直肠癌患者的益处Exercise and Metastatic Colorectal Cancer
              • 进阶之路专题：细胞疗法革新再登高峰popcart
              • 遗传性癌症风险：家长必知事项genetic cancer risk
              • 酒精摄入与个人健康：必知事项Alcohol Consumption and Personal Health
              • 针对头颈癌症的免疫疗法的更新immunotherapy for head and neck cancers
              • 针对患者与医护团队开启高难度谈话的建议tips for difficult conversations
              • 门诊干细胞移植和住院移植有何区别？inpatient outpatient SCT
              • 霍奇金淋巴瘤（HL）：最新的治疗及科研信息（至2019年7月）HL Updates 201907
              • 霍奇金淋巴瘤和非霍奇金淋巴瘤的区别是什么？ Lymphoma Differences
              • 青少年和青年患癌：基础事项Cancer in Adolescents and Young Adults
              • 青年男性睾丸癌的治疗Testicular Cancer in Young Men
              • 青年癌症患者保存生育能力：家长必知事项Fertility Preservation
              • 非经期出血是癌症的体征吗？spotting between periods
              • 非转移性前列腺癌患者的线上指南Online Tool for Non-Metastatic Prostate Cancer
              • 面对卵巢癌的诊断——她从医生变为患者的经历Dr. Luisa Stigol
              • 骑自行车会增加睾丸癌或前列腺癌的风险吗？Cycling Testicular or Prostate Cancer
              • 高危患者肺癌筛检的进步 Lung Cancer Screening
              • 黑色素瘤：定义、如何发现、治疗方案（至2019年8月）melanoma
            • Join Email
            • Leadership
            • Make an Appointment
              • Insurance and Financial Information
              • Preparing for Your First Appointment
              • Visitor Guidelines
            • Newsroom
              • “订书”抗微生物肽可抑制抗生素耐药性Stapled antimicrobial peptides
              • 60余年化疗药物新用：高剂量环磷酰胺可刺激免疫系统对淋巴瘤发起攻击Cyclophosphamide and immunotherapy
              • 60年后，科学家们发现沙利度胺导致先天畸形的原理thalidomide
              • DNA修复系统的缺失为对抗诸多癌症平添一处独特的契机Loss of a DNA repair system
              • Kevin Haigis博士任丹娜—法伯癌症研究所首席研究官一职
              • MPM资本出资一亿美元与丹娜—法伯癌症研究所成立专注于肿瘤学创新的新风险慈善基金会
              • Myles Brown博士获2019年度美国癌症研究协会（AACR）乳腺癌科研杰出教学奖
              • Stuart Orkin博士荣获2020年度费萨尔国王医学奖King Faisal Prize
              • 与运动相关的激素鸢尾素可作为关键骨细胞的靶点irisin
              • 个体化血液活检具有作为乳腺癌复发的早期警惕信号的潜能Personalized blood biopsies as early-warning signal of breast cancer recurrence
              • 丹娜—法伯临床研究中的新血检可检测多种癌症并对具有罹患癌症风险的个人开放New blood test can detect wide range of cancers, now available to at risk individuals in clinical study at Dana-Farber
              • 丹娜—法伯布莱根和妇女医院癌症中心就癌症治疗提供以核磁共振为指导的新型放射疗法MAPS MRILINAC
              • 丹娜—法伯布莱根和妇女医院癌症中心现供应新准入针对淋巴瘤CAR T-细胞治疗的Kymriah™药物
              • 丹娜—法伯布莱根和妇女医院癌症中心被《美国新闻与世界报道》评为最佳癌症医院之一2019-20 ranking DFBWCC
              • 丹娜—法伯护理科学家获得维多利亚·默克新晋研究员奖Victoria Mock New Investigator Award
              • 丹娜—法伯波士顿儿童医院癌症与血液疾病中心摘得2019年美国最佳儿科癌症排行榜桂冠DFBCH2019 ranking
              • 丹娜—法伯癌症所带领的罕见卵巢癌研究点亮表观遗传癌症演化的过程rare cancer epigentic process
              • 丹娜—法伯癌症研究所、诺华集团以及哈佛大学联手开发新一代用于免疫疗法的生物材料系统 - Dana-Farber Cancer Institute, Novartis and Harvard team up
              • 丹娜—法伯癌症研究所William G. Kaelin博士荣获2019年诺贝尔奖Nobel Prize
              • 丹娜—法伯癌症研究所与布莱根和妇女医院的科研人员高度赞赏针对非霍奇金淋巴瘤的CAR T-细胞疗法通过美国食品药品监督管理局批准CAR T-cell therapy for non-Hodgkin Lymphoma
              • 丹娜—法伯癌症研究所两位教授被评为美国国家医学院院士NAM
              • 丹娜—法伯癌症研究所中文官方网站正式上线-DFCI-CN-Website
              • 丹娜—法伯癌症研究所任命Melany Duval女士为资深副总裁兼首席发展官
              • 丹娜—法伯癌症研究所任命Moritz Kircher博士为影像学和放射学科主任
              • 丹娜—法伯癌症研究所医师名列《波士顿杂志》2017年最佳医生排行榜Top Doctors 2017
              • 丹娜—法伯癌症研究所发现一种肠肿瘤耐药性的诱因SDH GIST
              • 丹娜—法伯癌症研究所发现慢性淋巴细胞白血病生长模式patterns of CLL growth
              • 丹娜—法伯癌症研究所发现激活T-细胞关键部分的机制——以抗击癌症及其它疾病mechanism for activating T cells
              • 丹娜—法伯癌症研究所发现药物组合或可作为晚期肾癌的新标准疗法avelumab plus axitinib for advanced kidney cancer treatment
              • 丹娜—法伯癌症研究所发现遗传性胰腺癌风险突变RABL3
              • 丹娜—法伯癌症研究所因护理执业和患者护理的卓群成就而第四次蝉联磁性护理机构（Magnet®）认证
              • 丹娜—法伯癌症研究所团队发挥机器学习优势以鉴别胰腺癌高风险患病的人群AI pancreatic cancer
              • 丹娜—法伯癌症研究所团队发现：成体细胞几乎完整地保留了其产生自胚体细胞时期的分子“记忆”adult cell embryonic memory
              • 丹娜—法伯癌症研究所团队就骨髓瘤发展的前体症状和新型疗法作新研究报告precursor myeloma
              • 丹娜—法伯癌症研究所外科医师Beth Mittendorf博士将带领对抗三阴性乳腺癌的新科研团队
              • 丹娜—法伯癌症研究所就医疗暂缓遣返手续计划（Medical Deferred Action Program）发表声明
              • 丹娜—法伯癌症研究所布莱根和妇女医院癌症中心第十八年蝉联新英格兰地区最佳癌症中心及全美最佳癌症中心之一U.S. News and World Report 2018-19
              • 丹娜—法伯癌症研究所布莱根和妇女医院癌症中心连续第十七年获得地区最佳癌症护理机构荣誉奖项Dana-FarberBrigham and Women's Cancer Center the best in the region for cancer care for 17th year
              • 丹娜—法伯癌症研究所开发出诊断卵巢癌的新型血检New Blood Test Developed to Diagnose Ovarian Cancer
              • 丹娜—法伯癌症研究所开设改善患者报告结果的新研究项目SIMPRO
              • 丹娜—法伯癌症研究所开设青年结直肠癌中心以提高公众预防意识Young-Onset Colorectal Cancer Center
              • 丹娜—法伯癌症研究所开设首个预防疾病进展诊所CPOP
              • 丹娜—法伯癌症研究所成立Chen-Huang氏表皮生长因子受体突变肺癌中心
              • 丹娜—法伯癌症研究所成立莱尼家族多发性骨髓瘤项目Riney Multiple Myeloma Initiative
              • 丹娜—法伯癌症研究所成立首个林奇综合征中心Lynch Center
              • 丹娜—法伯癌症研究所携手Deerfield管理公司创立蛋白质降解研究中心protein degradation
              • 丹娜—法伯癌症研究所携手吉米基金会创建紧急响应基金Emergency Response Fund
              • 丹娜—法伯癌症研究所教学人员被评为2019年美国临床肿瘤学会癌症医护领导2019 ASCO leaders in cancer care
              • 丹娜—法伯癌症研究所教学团队在美国癌症研究协会2019年会上作报告DFCI faculty AACR 2019
              • 丹娜—法伯癌症研究所教授当选美国国家医学院院士NAM Wu Haas-Kogan
              • 丹娜—法伯癌症研究所教授荣获保罗∙艾伦杰出研究人员奖（Allen Distinguished Investigator）
              • 丹娜—法伯癌症研究所教授荣获欧洲临床肿瘤学会（ESMO）转化研究大奖
              • 丹娜—法伯癌症研究所新研究聚焦手术后乳腺癌幸存者面临的生命质量问题breast cancer survivors quality of life issues
              • 丹娜—法伯癌症研究所波士顿儿童医院再次荣登美国最佳儿童癌症中心排行榜2018-18DFBCH
              • 丹娜—法伯癌症研究所波士顿儿童医院癌症与血液疾病中心的科研团队获得美国联邦政府博∙拜登癌症探月计划项目补助金，以深入破解罕见儿童期癌症谜题Moonshot
              • 丹娜—法伯癌症研究所波士顿儿童医院蝉联美国顶级儿科癌症机构排行榜Best Pediatric Hospital 2017
              • 丹娜—法伯癌症研究所研究人员荣获胰腺癌基金会（Pancreatic Cancer Collective）颁发的新疗法挑战（“New Therapies Challenge”）资助金
              • 丹娜—法伯癌症研究所研究人员被美国癌症研究协会学院选为2019年度学者AACR Fellow
              • 丹娜—法伯癌症研究所研究团队为无症状瓦尔登斯特伦巨球蛋白血症患者开发以风险为基础的疾病演化分类模型AWM risk model
              • 丹娜—法伯癌症研究所研究团队在2018年美国血液学会年会上就白血病和淋巴瘤临床试验结果作报告ASH2018
              • 丹娜—法伯癌症研究所破解数十年来有关癌症最常见变异基因的谜题most commonly mutated gene in cancer
              • 丹娜—法伯癌症研究所破解的CDK46抑制剂非同寻常的耐药性机制或可逆转相关治疗reversible CDK46
              • 丹娜—法伯癌症研究所科学家发现与卵巢癌患病风险加重有关的基因34 genes and ovarian cancer development
              • 丹娜—法伯癌症研究所科学家发现针对侵袭性癌症的新药物靶点ncBAF
              • 丹娜—法伯癌症研究所科学家名列Web of Science Group2019年度高度引用名单
              • 丹娜—法伯癌症研究所科学家获陈-扎克伯格基金会开源软件项目资金CZI Open Source Project
              • 丹娜—法伯癌症研究所科研人员凭借其极具创新的研究项目荣获美国国立卫生研究院（NIH）新晋创新人员大奖New Innovator Award
              • 丹娜—法伯癌症研究所科研团队就提高髓细胞样癌症干细胞移植的疗效作新研究报告ASH2018 myeloid cancers
              • 丹娜—法伯癌症研究所联合吉米基金会发布新视觉标识new visual identity
              • 丹娜—法伯癌症研究所联手博德研究所创立以患者为合作伙伴的新科研项目CMI Brain Cancer Project
              • 丹娜—法伯癌症研究所董事会甄选出六位新董事six new board members 2023
              • 丹娜—法伯癌症研究所董事长Laurie H. Glimcher博士担任Stand Up To Cancer科学咨询委员会成员
              • 丹娜—法伯癌症研究所董事长兼首席执行官Laurie H. Glimcher博士当选美国哲学学会（APS）会员
              • 丹娜—法伯癌症研究所董事长兼首席执行官Laurie H. Glimcher博士荣获《现代医疗》杂志评选的50位最具影响力的医学高管及领导人之一
              • 丹娜—法伯癌症研究所被评选为马萨诸塞州最值得关注的由女性领导的公司及非营利性组织之一noteworthy MA companies and non-profits led by women
              • 丹娜—法伯癌症研究所证实靶向治疗对罕见侵袭性血癌具有疗效tagraxofusp
              • 丹娜—法伯癌症研究所逾110位医生荣登《波士顿杂志》2020年最佳医师排行榜Top Doctors 2020
              • 丹娜—法伯癌症研究所逾115位医生荣登《波士顿杂志》2018年最佳医师排行榜2018 Top Doctors
              • 丹娜—法伯癌症研究所针对子宫内膜癌患者开设一系列新的临床试验4new trials for endometrial cancers
              • 丹娜—法伯癌症研究所首创针对肾癌患者的个体化癌症疫苗临床试验personalized vaccine kidney cancer
              • 丹娜—法伯研究为近期获得FDA批准的前列腺癌药物提供新证据new evidence for enzalutamide
              • 丹娜—法伯研究人员将美国临床肿瘤学会2019年年会上就70余项科学发现进行报告ASCO 2019
              • 丹娜—法伯研究发现青年人群接触二手电子香烟气溶胶的现象有所上升second-hand e-cigarette aerosols
              • 丹娜—法伯科学家发现淋巴瘤患者或对特异性疗法产生耐药性，并提出应对策略Venetoclax resistance strategy
              • 丹娜—法伯科学家开发人类蛋白质相互作用参考图谱以发布有助于研究包括癌症和以COVID-19为代表的传染病数据reference map of human protein interactions
              • 丹娜—法伯科研团队对处于多发性骨髓瘤高风险患病的人群展开筛查研究multiple myeloma study
              • 丹娜—法伯科研团队获得胰腺癌基金会“新疗法挑战”补助金Pancreatic Cancer Collective “New Therapies Challenge” grant
              • 人工智能工具利用放射学报告识别癌症结果AI tool for imaging report
              • 人类表皮生长因子受体-2（HER2）突变可引发转移性激素受体阳性乳腺癌治疗的耐药性HER2 mutations MER breast cancer
              • 免疫检查点抑制药物耐药性与代谢失衡有关Resistance to immune checkpoint and metabolic imbalance
              • 利用“细胞社交网络”解密癌症 - Unlocking Cancer’s Secrets Using the Social Networks of Cells
              • 利用血液DNA排序对多发性骨髓瘤演化进行追踪-Tracking how multiple myeloma evolves by sequencing DNA in the blood
              • 单细胞分析揭示黑色素瘤细胞对免疫疗法呈抵抗性的机制single cell analysis
              • 博鳌中美乳腺癌高峰论坛在海南博鳌召开Boao
              • 在丹娜—法伯癌症研究所科研的基础上，美国食品药品监督管理局（FDA）批准用于治疗晚期肾癌的新药组合FDA approval of avelumab and axitinib
              • 基因标记或可预测能够从免疫疗法药物中获益的黑色素瘤患者 - Genetic markers may predict which melanoma patients benefit from immunotherapy drug
              • 多种类型癌症内基因路径变化的综合图谱将引领精准癌症医学研究-Comprehensive map of altered gene pathways in dozens of cancer types will guide research in precision cancer medicine
              • 大型筛查研究开发出数十种潜在的抗癌药物potential anti-cancer drugs netted in massive screening study
              • 小分子抑制剂在肺癌和结直肠癌患者中呈现临床活性MRTX849
              • 快速生长的卵巢癌类器官模型可助力迅速选择药物疗法organoid
              • 恩杂鲁胺改善转移性激素敏感性前列腺癌男性的生存率Enzalutamide mHSPC
              • 患者同科学家合作抗击转移性前列腺癌 - Patients and researchers team up to fight metastatic prostate cancer
              • 手术前期的免疫疗法试验在早期肺癌患者中呈现希望presurgical immunotherapy early stage lung cancer
              • 手术的选择或影响年青乳腺癌幸存者的生命质量choice of surgey quality of life
              • 探究检查点抑制剂在捐献干细胞移植后血癌复发后的使用-Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant for hematologic cancers
              • 放疗使肺癌患者的心脏风险上升raiotherapy and cardiac events
              • 新CRISPR-Cas9基因检测技术助力开发新药物靶点以辅助癌症免疫疗法
              • 新免疫程序的发现可为提高疼痛治疗水平添砖加瓦IRE1α-XBP1 and pain management
              • 新生抗原疫苗激发胶质母细胞瘤的免疫反应neoantigen vaccine glioblastoma
              • 新血检可检查出多个癌症病种new blood test and multiple cancers detection
              • 新靶向药之于晚期肾癌的治疗大有裨益MK6428 for advanced kidney cancer
              • 晚期结直肠癌患者可从运动中受益advanced colorectal cancer and exercise
              • 晚期结直肠癌患者可因摄入高剂量的维生素D而受益sunshine trial
              • 有关乳腺癌治疗耐药性机制的研究迎来新的曙光 Breast Cancer Treatment Resistance
              • 有关多发性骨髓瘤基因组变化的研究或可开启早期冒烟型骨髓瘤的治疗SMM
              • 术前免疫疗法在口腔癌治疗中呈现希望Pre-operative immunotherapy shows promise in oral cancers
              • 治疗早期急性髓细胞白血病（AML）的维奈托克组合疗法获得批准Venetoclax combination
              • 用义务性基因检测和咨询识别更多胰腺癌基因突变Mandatory Genetic Testing for PC
              • 白鼠实验发现肿瘤手术中缓慢释放的免疫疗法能够防止肿瘤复发且减缓癌症扩散-Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning and eliminates cancer spread in mouse study
              • 研究发现：10%的胰腺癌患者携带遗传基因变种-gene variants in pancreatic cancer patients
              • 研究发现PARP抑制剂药物可唤醒免疫系统对一些卵巢癌症发起攻击PARP ovarian cancer
              • 研究发现一种基本的单次睡眠教育课程可治愈癌症生存者的慢性失眠症single sleep education session
              • 研究发现免疫疗法的耐药性机制-Mechanism for resistance to immunotherapy treatment discovered
              • 研究发现安慰剂能改善癌症幸存者因癌症引起的疲累感——即使患者知晓其所用药物无任何疗效placebo
              • 研究发现对前列腺癌患病风险低的人群进行“积极监测”的高潮正不断兴起active surveillance for LRPC
              • 研究发现抑制细胞周期的药物可通过动员免疫系统攻击癌症来致使肿瘤缩小Cell cycle-blocking drugs
              • 研究发现肿瘤微环境损害免疫T-细胞的机制IRE1alpha-XBP1
              • 研究发现胰腺癌早期发展阶段有边缘脂肪与肌肉减少的现象peripheral fat and muscle
              • 研究发现转移性且与人类乳头状瘤病毒相关的头颈癌症或可助力指导相关疗法
              • 研究发现黑色素瘤生物标记能够预测检查点抑制剂反应melanoma biomarkers predicting checkpoint blocker response
              • 研究提出抗击备受瞩目而难懂的癌症靶向的新策略 Discovery suggests new strategy for attacking high-profile but elusive target in cancer
              • 研究揭露性取向与人口因素交集之于易受烟草广告影响的关系sexual orientation and demo factors versus vulnerability to tobacco ads
              • 研究表明模拟宿主细胞受体的化合物在防御HIV-1传染方面展现希望CD4
              • 研究表明聚腺苷二磷酸核糖聚合酶（PARP）抑制剂可使一些卵巢癌患者受益PARP and Ovarian Cancer
              • 研究表明膳食可降低三期结肠癌复发的风险diet and colon cancer
              • 科学家发现预测合类卵巢癌患者无法从免疫和PARP抑制剂组合疗法中获益的因素PARP benefits for advanced ovarian cancer
              • 科学家开发出肿瘤对免疫检查点抑制剂药物反应机制的模型
              • 科学家开发分子工具以剔除痴呆症神经细胞模型中的毒性蛋白toxic protein dimentia
              • 科学家揭露前列腺癌近百种基因突变的 “长尾” 效应 - Scientists uncover “long tail” of nearly 100 genes mutated in prostate cancer
              • 科研团队、癌症患者及慈善人士组建名为“加我在内”（Count Me In）的患者合作研究新模型以加快抗击癌症的步伐
              • 第一二阶段临床试验表明——免疫疗法聚腺苷二磷酸核糖聚合酶抑制剂（PARP）组合用药与单项用药相比有更高的卵巢癌缓解比例 - ImmunotherapyPARP inhibitor combination
              • 组合免疫疗法可改善晚期黑色素瘤患者的幸存率Immunotherapy combination improves survival in advanced melanoma
              • 美国国家癌症研究所为丹娜—法伯癌症研究所研究员颁发杰出科研人员大奖OIA
              • 美国地方法院作出裁决：承认丹娜—法伯癌症研究所科学家为六项重大免疫疗法专利的发明人Court patents
              • 美国食品药品监督管理局（FDA）批准丹娜—法伯研发的新肾癌药物 - Backed by Dana-Farber research, FDA approves new indication for a kidney cancer drug
              • 美国食品药品监督管理局（FDA）批准基于丹娜—法伯布莱根和妇女医院癌症中心研究而开发的新药——以帮助某些细胞移植患者预防一种常见病毒感染new drug to prevent a common virus infection in certain cell transplant patients
              • 美国食品药品监督管理局（FDA）批准基于丹娜—法伯癌症研究所科研成果的用来治疗急性髓性白血病（AML）的新药
              • 聚腺苷二磷酸核糖聚合酶抑制剂-靶向疗法组合对对化疗呈耐药性的卵巢癌患者的疗效远超聚腺苷二磷酸核糖聚合酶抑制剂单药疗效PARP and alpelisib
              • 胰腺癌神经内分泌亚型的发现可助力癌症复发可能性的预测pNETs
              • 脑癌患者的生存率因免疫疗法的治疗时机而提高近两倍timing of immunotherapy for brain cancer
              • 芳香化酶抑制剂与抑制卵巢功能的组合疗法在治疗高危性绝经前期乳腺癌患者方面呈现优势-Aromatase
              • 血液检查具备探测早期肺癌的潜力 Blood Test Lung Cancer
              • 行走速度为老年血液癌症患者指向未来临床结果walking speed
              • 运动可有效减少结肠癌患者循环肿瘤细胞数量CTCs
              • 逆向开发案例：丹娜—法伯科学家们破解肠自愈机制的长期争论ISCs
              • 重症疾病护理的新研究彰显临床人员和患者之间展开更多、更好及更早对话的益处Serious Illness Care Program
              • 针对卵巢癌的临床试验彰显免疫疗法和第二种药物结合的前景niraparib+pembrolizumab
              • 针对晚期胰腺癌的实时DNA测序可指导精准医学疗法Pancreatic Cancer
              • 针对晚期黑色素瘤的组合免疫疗法凸显高幸存率combo immunotherapy advanced melanoma
              • 长期吸食大麻的男性艾滋病毒携带者与罹患肺疾病风险加剧相关marijuana and increased pulmonary disease in HIV-positive men
              • 非编码DNA揭示晚期前列腺癌对疗法呈抵抗性的路径Non-coding DNA
              • 预测转移性前列腺癌的新生物标记New biomarker predicts metastatic prostate cancers
              • 香港浸信会医院护理团队到访丹娜—法伯癌症研究所并展开深入探讨HKBH nursing
              • 骨肉瘤研究所资助丹娜—法伯波士顿儿童医院癌症与血液疾病中心开展复发性骨肉瘤临床试验OSI and DFBC trial
              • 高剂量维他命D疗法或可延缓转移性结直肠癌的进展VitaminD
            • Services
        • Patient Communications
          • Automated Appointment Reminders
          • E-Bulletins for Patients and Families
          • Email Use Guidelines
          • How Dana-Farber Uses Email to Connect with Patients
        • Patient Safety and Advocacy
          • Chaperone Policy for Patients
          • LGBTQ Patient Care and Support
            • Advocacy
            • Equality and Equity
            • Providers
            • Resources
          • Patient and Family Advisory Councils
            • Adult Patient and Family Advisory Council
            • Pediatric Patient and Family Advisory Council
          • Patient Family Relations Program
          • Politica de acompanantes para pacientes
          • Safety Information for Patients
        • Planning Your Visit
          • Free Flight Resources
          • Places to Eat Near Dana-Farber
          • Places to Stay Near Dana-Farber
        • Practical and Legal Matters
          • Compliance Program
          • Disability Claims and Family Medical Leave Act
          • Health Care Proxy
          • Medical Records
          • Non-Discrimination Notice
          • Patient Rights and Responsibilities
          • Privacy and Confidentiality
        • Preparing for Your First Appointment
          • Checklist for New Adult Patients
          • Outpatient Visitor Guidelines
          • Tips for Talking with Your Doctor
          • What to Expect at Your First Appointment
        • Virtual Visits
      • Cancer Prevention & Risk Reduction
      • Care and Treatment
        • Cancer Types
        • Nursing and Patient Care
          • About Nursing and Patient Care Services
          • Dana-Farber Registered Nurse Residency Program
          • Magnet Recognition Program
          • Our Leadership Team
          • The DAISY Award in Nursing
        • Support Services and Amenities
          • Adult Social Work Program
          • Back to School Program
          • Bereavement Support
          • Concierge Services
          • Disability Services
          • Ethics Consultation Service
          • Exercise Classes and Consults
          • Expressive Arts Therapy
          • Family Connections
            • Debbys Gift
            • For Survivors
              • How Children May React After Cancer
              • How Your Familys Life Will Change After Cancer
            • For the Family
              • Financial and Legal Concerns
              • Form a Support System
                • The Daily Routine
              • Reassess Your Expectations
              • Reflect on Your Familys Needs
              • Take Care of Yourself
              • Think About Your Reactions to Cancer
              • Your Role in Medical Care
            • For the Patient
              • How to Explain Treatment
              • How to Help Children Cope
              • Medical Terms Made Easy
              • Questions Parents Often Ask
              • Stress Warning Signs in Children
              • Talking with Children About Cancer
              • Talking with Your Childs School
              • What Children Want to Know
          • Friends Place
            • How to Support Us
            • Services and Programs
              • Breast Prostheses and Bras
              • Caring for Skin and Nails
              • Compression Garments
              • Wigs and Hair Prostheses
          • Gift Shop
          • Hospital-to-Home Visits
          • Interpreter Services
          • Just for Teens
          • Nutrition Services
            • Events
            • FAQs
              • Fasting
              • Organic Food
              • Soy and Cancer
              • Sugar and Cancer
              • Superfoods
            • Managing Cancer Side Effects
            • Meal Planning
            • Our Team
            • Resources
          • One-to-One
          • Parents Together
          • Patient and Family Resource Centers
            • Adult Resources
            • Contact Us
            • Pediatric Resources
            • Program Calendar
          • Patient Financial Assistance
          • Patient Navigator Program
          • Patient Websites
          • Pediatric Resource Program
          • Pharmacy
          • School Liaison Program
          • Sexual Health Program
            • For Cancer Survivors
          • Sibling Program
          • SoulMates
          • Spiritual Care
            • Chaplain Intern Program
            • Chaplaincy Volunteers
            • Contact Us
            • Dana-Farber Chapel
            • Our Staff
          • Support Groups and Seminars
          • Young Adult Program
            • Resources for Young Adults with Cancer
            • YAP Offerings
          • Zakim Center for Integrative Therapies
            • Acupuncture
            • Contact Us
            • Expressive Arts Therapy
            • Healthy Living Program
            • Massage Therapy
            • Meditation and Mindfulness
            • Our Team
            • Pediatric Offerings
            • Program Calendar
        • Treatment Centers
          • Adolescent and Young Adult Neuro-Oncology Program
          • Adult Fertility Preservation Program
          • Adult Palliative Care
            • Contact Us
            • Our Team
          • Adult Psychosocial Oncology
            • Billing and Privacy
            • Contact Us
            • Our Team
          • Adult Survivorship Program
            • Care Team
            • Contact Us
            • FAQ
            • Resources
          • Breast Oncology Program
            • Cancer Types and Programs
              • Breast Cancer
                • About
                • Diagnosis
                • Our Team
                • People at Higher Risk
                • Treatment
              • Breast Cancer during Pregnancy Program
                • Contact Us
                • Our Team
                • Patient Resources
              • Ductal Carcinoma in Situ Program
                • Clinical Trials and Research
                • Contact Us
                • Our Team
              • Inflammatory Breast Cancer Program
                • Clinical Research
                • Contact Us
                • Inflammatory Breast Cancer Patient Forum Highlights
                • Our Team
                • Patient Journeys
                • Support and Education
              • Metastatic Breast Cancer Program
                • Clinical Research and Trials
                • How to Choose a Treatment Center for Metastatic Breast Cancer
                • Metastatic Breast Cancer Forum Highlights
                • Our Patients
                • Support and Education
              • Program for Breast Cancer in Men
                • Clinical Trials and Research
                • Contact Us
                • Our Team
              • Program for Older Women with Breast Cancer
                • Our Team
                • Research and Clinical Trials
                • Support and Education
              • Program for Patients with Breast Cancer Brain Metastases
                • Our Treatment Team
                • Research and Clinical Trials
              • Young and Strong Program for Young Women with Breast Cancer
                • Clinical Services
                  • How to Choose a Treatment Center for Young Women with Breast Cancer
                • Contact Us
                • Patient Journeys
                  • Alexis Breast Cancer Journey
                • Research
                • Support and Education
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
            • SABCS
          • Cancer Genetics and Prevention
            • Contact Us
            • Genetic Testing
            • Our response to COVID-19
            • Our Team
            • Research
              • PROACTIVE Research Study
            • Syndromes Genes and Programs
              • Breast and Ovarian Cancer Genetics and Prevention
              • Gastrointestinal Cancer Genetics and Prevention Program
              • Li-Fraumeni Syndrome and TP53 Center
                • Clinical Services
                • Contact Us
                • For Providers Referring Patients
                • Our Team
                • Patient Events and Resources
                • Research
              • Lynch Syndrome Center
                • Contact Us
                • For Providers Referring Patients
                • Our Team
                • Patient Events and Resources
                • Research
          • Cellular Therapies Program
            • CAR T-Cell Therapy
              • CAR T-Cell Therapy for Leukemia
                • FAQ About CAR T-Cell Therapy for Leukemia
                • Key Eligibility Criteria
              • CAR T-Cell Therapy for Lymphoma
                • FAQ About CAR T-Cell Therapy for Lymphoma
                • Key Eligibility Criteria
              • CAR T-Cell Therapy for Multiple Myeloma
                • FAQ About CAR T-Cell Therapy for Multiple Myeloma
                • Key Eligibility for CAR T for Multiple Myeloma
              • FAQ About CAR T-Cell Therapy
              • How CAR T-Cell Therapy Works
              • Referrals and Contact Information
            • Clinical Trials
            • Our Team
            • Tumor Vaccines
            • Types of Cellular Therapies
          • Center for Cancer Therapeutic Innovation
            • Clinical Research and Trials
            • Contact Us
            • Our Team
          • Center for Global Cancer Medicine
            • Education and Training Initiatives
            • Haiti Clinical Care
            • Nursing Initiative
            • Our Team
            • Research and Publications
            • Rwanda Clinical Care
          • Center for Immuno-Oncology
            • Contact Us
            • Immunotherapy
            • Our Team
          • Center for Neuro-Oncology
            • Cancer Types and Programs
              • Brain Metastases Program
                • Contact Us
                • Treatment Approach
                • Treatment Team
              • Brain Tumors
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • CNS Lymphoma Center
                • Contact Us
                • Treatment Approach
                • Treatment Team
            • Clinical Research and Trials
              • Genotyping
              • Immunotherapy Research
              • Targeted Therapies Research
            • Contact Us
            • Our Approach
            • Our Team
          • Chemotherapy
            • Infusion
            • Oral Chemotherapy
          • Childhood Blood Disorders Center
            • Blood Disorder Types and Programs
              • Childhood Aplastic Anemia
              • Childhood Bone Marrow Failure
              • Childhood Chronic Granulomatous Disease
              • Childhood Diamond-Blackfan Anemia
              • Childhood Dyskeratosis Congenita
              • Childhood Fanconi Anemia
              • Childhood Immune Thrombocytopenia
              • Childhood Myelodysplastic Syndrome
              • Childhood Polycythemia
              • Childhood Shwachman-Diamond Syndrome
              • Childhood Sickle Cell Disease
              • Childhood Thalassemia
              • Childhood White Blood Cell Disorders
              • Hemolytic Disease of the Newborn
            • Our Team
          • Childhood Brain Tumor Center
            • Brain Tumor Types and Programs
              • Childhood Anaplastic Astrocytoma
              • Childhood Astrocytoma
              • Childhood Atypical Teratoid Rhabdoid Tumor
              • Childhood Choroid Plexus Tumor
              • Childhood Craniopharyngioma
              • Childhood Diffuse Intrinsic Pontine Glioma
              • Childhood Dysembryplastic Neuroepithelial Tumor
              • Childhood Ependymoma
              • Childhood Ganglioglioma
              • Childhood Germ Cell Tumor of the Brain
              • Childhood Germinoma
              • Childhood Glioblastoma Multiforme
              • Childhood Glioma Program
              • Childhood Gliomatosis Cerebri
              • Childhood Low-Grade Gliomas
              • Childhood Medulloblastoma
              • Childhood Medulloblastoma Program
              • Childhood Meningioma
              • Childhood Oligodendroglioma
              • Childhood Optic Nerve Glioma
              • Childhood Pilocytic Astrocytoma
              • Childhood Pleomorphic Xanthoastrocytoma
              • Childhood Primitive Neuroectodermal Tumors and Pineoblastoma
              • Childhood Schwannoma
              • Childhood Spinal Cord Tumor
              • Childhood Tectal Glioma
              • Childhood Thalamic and Hypothalamic Astrocytoma
            • Clinical Trials and Research
            • Contact Us
            • Our Team
          • Childhood Hematologic Malignancy Center
            • Blood Cancer Types and Programs
              • Childhood Acute Lymphoblastic Leukemia
                • Diagnosis
                • Our Team
                • Treatment
              • Childhood Acute Myeloid Leukemia
                • Diagnosis
                • Our Team
                • Treatment
              • Childhood Anaplastic Large Cell Lymphoma
              • Childhood Burkitt Lymphoma
              • Childhood Chronic Myeloid Leukemia
                • Diagnosis
                • Our Team
                • Treatment
              • Childhood Diffuse Large B-cell Lymphoma
              • Childhood Hemophagocytic Lymphohistiocytosis
              • Childhood Histiocytosis Program
              • Childhood Hodgkin Lymphoma
                • Diagnosis
                • Our Team
                • Treatment
              • Childhood Langerhans Cell Histiocytosis
              • Childhood Leukemia Program
                • Diagnosis
                • Our Team
                • Treatment
              • Childhood Lymphoblastic Lymphoma
              • Childhood Lymphoma Program
              • Childhood Non-Hodgkin Lymphoma
                • Diagnosis
                • Our Team
                • Treatment
              • Childhood Primary Mediastinal B-cell Lymphoma
              • Juvenile Myelomonocytic Leukemia
                • Diagnosis
                • Our Team
                • Treatment
              • Node Assessment Program
              • Rare Childhood Non-Hodgkin Lymphomas
              • Relapsed Childhood Acute Lymphoblastic Leukemia
            • Clinical Trials and Research
            • Contact Us
            • Our Approach
            • Our Team
          • Childhood Solid Tumor Center
            • Contact Us
            • Our Team
            • Solid Tumor Types and Programs
              • Childhood Adamantinoma
              • Childhood Adrenal Tumors
              • Childhood Adrenocortical Carcinoma
              • Childhood Alveolar Soft Part Sarcoma
              • Childhood Angiosarcoma
              • Childhood Bone and Soft Tissue Tumors Program
              • Childhood Carcinoid Tumors
              • Childhood Carney Triad
              • Childhood Chondrosarcoma
              • Childhood Desmoid Tumors
              • Childhood Endocrine-Oncology Program
              • Childhood Ewing Sarcoma
              • Childhood Fibrosarcoma
              • Childhood Germ Cell Tumors
              • Childhood Hepatoblastoma
              • Childhood Hepatocellular Carcinoma
              • Childhood Kidney Tumor Program
              • Childhood Leiomyosarcoma
              • Childhood Liposarcoma
              • Childhood Liver Tumor Center
              • Childhood Malignant Fibrous Histiocytoma
              • Childhood Malignant Rhabdoid Tumor
              • Childhood Melanoma
              • Childhood Multiple Endocrine Neoplasia
              • Childhood Nasopharyngeal Carcinoma
              • Childhood Neuroblastoma
              • Childhood Neuroblastoma Program
              • Childhood Neuroendocrine Tumors
              • Childhood Ocular Oncology Service
              • Childhood Osteosarcoma
              • Childhood Ovarian Tumors
              • Childhood Pancreatic Tumors
              • Childhood Peripheral Nerve Sheath Tumor
              • Childhood Pheochromocytoma and Paraganglioma Tumors
              • Childhood Rare Tumors Program
              • Childhood Retinoblastoma
              • Childhood Rhabdomyosarcoma
              • Childhood Soft Tissue Sarcomas
              • Childhood Synovial Sarcoma
              • Childhood Testicular Tumors
              • Childhood Thyroid Carcinoma
              • Childhood Wilms Tumor
              • Pediatric Carcinoma Clinic
                • Our Team
          • Cutaneous Skin Cancer Treatment Center
            • Cancer Types and Programs
              • Merkel Cell Carcinoma
                • Our Approach
                • Our Team
              • Skin Cancer
                • Our Team
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • Division of Stem Cell Transplantation and Cellular Therapies
          • Gastrointestinal Cancer Treatment Center
            • Cancer Types and Programs
              • Anal Cancer
                • Our Team
              • Biliary Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Center for Esophageal and Gastric Cancer
                • Contact Us
                • Our Team
                • Support Programs
              • Colon and Rectal Cancer Center
                • Contact Us
                • Our Approach
                • Our Specialists
              • Colon Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Esophageal Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Gastrointestinal Carcinoid Tumor
                • Our Team
              • Hepatocellular Carcinoma
                • Our Team
              • Intrahepatic Cholangiocarcinoma
                • Our Team
              • Liver Cancer
                • Our Team
              • Liver Cancer Center
                • Clinical Trials and Research
                • Contact Us
                • For Referring Providers
                • Our Approach
                • Our Team
              • Neuroendocrine and Carcinoid Tumors Program
                • Contact Us
                • FAQ
                • Our Specialists
                • Patient Support
                • Research
              • Pancreas and Biliary Tumor Center
                • Contact Us
                • Our Approach
                • Our Research
                • Our Team
              • Pancreatic Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Pheochromocytoma and Paraganglioma Syndromes
              • Rectal Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Stomach Gastric Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Young-Onset Colorectal Cancer Center
                • Contact Us
                • Our Specialists
                • Patient Events
                • Research and Clinical Trials
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • Genitourinary Cancer Treatment Center
            • Cancer Types and Programs
              • Adrenocortical Carcinoma
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Bladder Cancer
                • About
                • Diagnosis
                • Ongoing Research
                • Our Team
                • Treatment
              • Kidney Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Penile Cancer
                • Our Team
              • Prostate Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Testicular Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • Global Health Initiative
          • Gynecologic Oncology Program
            • Cancer Types and Programs
              • Cervical Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Endometrial Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Gestational Trophoblastic Disease
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Ovarian Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Vaginal Cancer
                • Our Team
              • Vulvar Cancer
                • Our Team
            • Clinical Research and Trials
            • Contact Us
            • Gynecologic Patient Symposium Highlights
            • Our Approach
            • Our Team
          • Head and Neck Cancer Treatment Center
            • Cancer Types and Programs
              • Center for Salivary and Rare Head and Neck Cancers
                • Clinical Trials and Research
                • Contact Us
                • Our Team
              • Mouth Oral Cavity Cancer
                • Our Team
              • Salivary Gland Cancer
                • Our Team
              • Throat Laryngeal Cancer
                • Our Team
              • Thyroid Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Thyroid Cancer Center
                • Clinical Research
                • Contact Us
                • Our Approach
                • Our Specialists
                • Thyroid Cancer 360 Program
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • Hematologic Oncology Treatment Center
            • American Society for Hematology Annual Meeting
            • American Society of Hematology Previous Meetings
            • Cancer Types and Programs
              • Acute Lymphoblastic Leukemia ALL
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Acute Myeloid Leukemia AML
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Adult Bone Marrow Failure Syndromes
                • Diagnosis and Treatment
                • Our Team
              • Adult Histiocyte Disorders Center
                • Collaborations and Research
                • Contact Us
                • Our Approach
                • Our Team
              • Adult Leukemia Program
                • Clinical Research and Trials
                • Contact Us
                • Our Team
              • Amyloidosis Program
                • Contact Us
                • Our Approach
                • Our Team
                • Research
              • BPDCN Center
                • Contact Us
                • Our Approach
                • Our Team
                • Research
              • Center for Chronic Lymphocytic Leukemia
                • Clinical Research and Trials
                • Contact Us
                • Our Team
              • Center for Prevention of Progression
                • Conditions Treated
                • Contact Us
                • Our Approach
                • Our Team
                • Research
              • Chronic Lymphocytic Leukemia CLL
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Chronic Myelogenous Leukemia CML
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Histiocytosis
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Hodgkin Lymphoma
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Lymphoma Program
                • Clinical Research and Trials
                • Contact Us
                • Our Team
              • Multiple Myeloma
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Multiple Myeloma Program
                • Clinical Research and Trials
                • Contact Us
                • Our Team
              • Myelodysplastic Myeloproliferative Diseases
                • Our Team
              • Non-Hodgkin Lymphoma
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Older Adult Hematologic Malignancy OHM Program
                • Conditions
                • Information for Patients
                • Leadership
                • Research
              • The Bing Center for Waldenstroms Macroglobulinemia
                • Clinical Research and Trials
                • Contact Us
                • Our Team
              • Waldenstroms Macroglobulinemia
                • About
                • Diagnosis
                • Our Team
                • Treatment
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
            • Preview of ASH 2017 Highlights Ken Anderson
          • Hematology Treatment Center
            • Blood Disorder Types
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • Imaging Services
            • Contact Us
            • FAQ
            • Our Approach
            • Our Team
          • Inpatient Care
            • Care Team
            • Clinical Services
            • Hospital Information
            • Research Initiatives
          • Melanoma Treatment Center
            • Cancer Types and Programs
              • Melanoma
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Ocular Melanoma Center
                • Contact Us
                • Our Approach
                • Our Research
                • Our Team
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • MIBG Therapy for Childhood Neuroblastoma
            • What to Expect
          • Oral Medicine and Oral Oncology
            • Contact Us
            • FAQ
            • For Dental Professionals
            • Our Approach
            • Our Team
            • Patient Resources
          • Pathology
            • Contact Us
            • Our Services
          • Pediatric Advanced Care Team
          • Pediatric Cancer Genetic Risk Program
          • Pediatric CAR T-Cell Therapy Program
            • Contact Us
            • Frequently Asked Questions
            • Our Team
          • Pediatric Chemotherapy
          • Pediatric Fertility Preservation Program
          • Pediatric Imaging Services
          • Pediatric Inpatient Care
          • Pediatric Outpatient Care
          • Pediatric Pathology
          • Pediatric Psychosocial Oncology Program
            • Care Team
            • Contact Us
            • Services
          • Pediatric Radiation Oncology
          • Pediatric Stem Cell Transplant Program
            • About SCT
            • Conditions We Treat
            • Contact Us
            • Finding a Stem Cell Donor for Your Child
            • Our Approach
            • Our Team
          • Pediatric Survivorship Programs
            • Childhood Cancer Survivors
            • Davids Clinic
            • Pediatric Brain Tumor Survivors
          • Radiation Oncology
            • Clinical Research
            • Contact Us
            • Our Approach
            • Our Team
            • Safety
          • Sarcoma and Bone Cancer Treatment Center
            • Cancer Types and Programs
              • Bone Cancer Osteosarcoma
                • Our Team
              • Ewing Sarcoma
                • Our Team
              • Gastrointestinal Stromal Tumor GIST
                • Our Team
              • Kaposi Sarcoma
                • Our Team
              • Soft Tissue Sarcoma
                • Our Team
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
          • Science Health Education Center
            • Education and Training
            • Events and Projects
            • Leadership
            • Research
            • Staff Collaborators and Partners
          • Stem Cell Transplantation Program
            • Clinical Research and Trials
            • Contact Us
            • Our Team
            • Resources
              • How to Choose a Stem Cell Transplant Center
              • Resources Beyond Dana-Farber
              • Resources Especially for Caregivers
              • Stem Cell Transplantation An Information Guide for Patients and Caregivers
            • Transplant Basics
          • Surgical Oncology
            • Contact Us
            • Our Approach
          • Susan F Smith Center for Womens Cancers
            • Cancer Care
            • Get Involved
              • Executive Council
              • Susan F. Smith
            • Our Research
            • The Center
          • Thoracic Lung Cancer Treatment Center
            • Cancer Types and Programs
              • Chen-Huang Center for EGFR-Mutant Lung Cancers
                • Clinical Trials
                • Contact Us
                • Our Team
              • Mesothelioma
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Non-Small Cell Lung Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • NUT Carcinoma
                • Our Approach
                • Our Team
              • Small Cell Lung Cancer
                • About
                • Diagnosis
                • Our Team
                • Treatment
              • Thymomathymic Malignancies
            • Clinical Research and Trials
            • Contact Us
            • Our Approach
            • Our Team
        • Your Care Team
        • Caring for a Loved One
          • Caring for Yourself
          • Resources & Information
          • Suggested Reading
          • The Experience of Caregiving
        • For Survivors
          • Caring for Yourself after Cancer
            • Developing a Wellness Plan
            • Finding Meaning
            • Joining a Support Group
            • Medical Care after Treatment
            • Social Relationships
            • Support Services for Cancer Survivors
            • Where to Find Help
            • Your Body after Treatment
            • Your Emotions after Treatment
          • Celebrating Survivorship
          • Education and Support
            • Events and Classes
            • Information Sheets
          • Stories from Survivors
            • Charlies Story
            • Dan and Dianes Story
            • Eds Story
            • Julies Story
            • Karis Story
            • Magnolias Story
        • My Dana-Farber
          • Care Card
          • Dana-Farber CancerConnect
          • myDFCI App
          • Partners Patient Gateway
        • Why Dana-Farber
          • Patient Satisfaction
            • Patient Ratings Blood Cancer
            • Patient Ratings Brain Tumor
            • Patient Ratings Breast Cancer
            • Patient Ratings Gastrointestinal
            • Patient Ratings Genitourinary
            • Patient Ratings Gynecologic
            • Patient Ratings Head and Neck
            • Patient Ratings Lung Cancer
            • Patient Ratings Melanoma
            • Patient Ratings Network Sites
            • Patient Ratings Sarcoma
            • Patient Ratings Skin Cancer
          • Patient Stories
          • Quality and Patient Safety
            • Creating a Culture of Quality and Safety
              • CPiP
              • PiP
              • Safety Culture Survey
              • Team Training
            • Improving and Innovating
              • eSyM Tool for Patients
              • Flu Vaccination Program
              • Medication Management
              • Pathways
              • Patient Reported Data
                • Informacion proporcionada por el paciente
            • Leadership Team
            • Measuring Quality and Safety
              • Accreditations and Certifications
              • Infection Control Initiatives
              • Patient and Family Satisfaction
              • Publicly Reported Measures
      • For Physicians
        • Clinical Resources
          • Cancer Diagnostic Service
          • Hematologic Malignancies Resources
            • Advances in Hematologic Malignancies Newsletter
              • Issue 1 Spring 2013
                • Clinical Trial Summary: Adult Lymphoma Program
                • Comments from George P. Canellos, MD
                • Complex Case Study: Early T-Cell Precursor Lymphoblastic Lymphoma
                • Patient Care Spotlight: Lymphoma and the Dana-Farber Cancer Institute Adult Survivorship Program
                • Research Spotlight: Large B-Cell Lymphoma
                • Welcome from the Editors
              • Issue 10 Spring 2019
                • Advances in Multiple Myeloma Precursor Diseases
                • Amyloidosis Program
                • An Update on CAR T-Cell Therapy in Multiple Myeloma
                • Faculty Spotlight Omar Nadeem MD
                • Transplant in Multiple Myeloma
              • Issue 11 Fall 2019
                • CAR T-cells Off-trial
                • Duvelisib and Venetoclax for CLL
                • Faculty Spotlight Reid Merryman, MD
                • Improving Quality of Life for Lymphoma Patients
                • Peripheral T Cell Lymphoma
              • Issue 12 Summer 2020
                • Dual ABL Inhibition
                • Faculty Spotlight Rahul Vedula MD
                • How Venetoclax Is Being Used
                • New Edward P. Evans Center for MDS
                • Telomere Length and Mutations
              • Issue 13 Winter 2021
                • Allogeneic SCT for Older MDS Patients
                • Arming Memory-Like NK Cells
                • ASH 2020 Reflections from Our New Editors
                • CAR T-Cells for Indolent B-Cell Non-Hodgkin Lymphoma
                • High-Dose Melphalan and MM
              • Issue 14 Spring 2021
                • Anti-CD123 Chimeric Antigen T Cells for BPDCN
                • CAR T-Cell Therapy Approved for Multiple Myeloma
                • Faculty Spotlight Eric Smith MD PhD
                • Immune Effector Cell Therapy in Solid Tumors
                • Matched Unrelated vs Haplo Donors in Allogeneic SCT
              • Issue 2 Fall 2013
                • Complex Case Study: Multiple Myeloma with Secondary Light Chain Amyloidosis
                • Introduction by Robert Kyle, MD
                • New Program Physician in Waldenström's Macroglobulinemia
                • Patient Care Spotlight: Current Management of Hypercalcemia Associated with Multiple Myeloma
                • Research Spotlight: Bench to Bedside Translation of Targeted Therapeutics in Multiple Myeloma
              • Issue 3 Spring 2014
                • Clinical Practice Spotlight: Management of Graft-versus-Host-Disease (GVHD)
                • Clinical Trial Spotlight: Bortezomib-Based GVHD Prophylaxis
                • Complex Case Study: Four Stem Cell Transplants for Acute Myeloid Leukemia (AML)
                • Complex Case Study: The Patient's Perspective
                • Introduction by Joseph Antin, MD
                • Research Spotlight: Transformation of Hematopoietic Cell Transplantation from Stem to Stern
              • Issue 4 Summer 2016
                • Clinical Practice Spotlight: Preparing for Blinatumomab and CAR T-cell Therapies
                • Clinical Trial Spotlight: Trial Num14-195: ASTX727-01
                • Complex Case Study: Using Genomic Testing to Tailor Treatment for Acute Myeloid Leukemia
                • Research Spotlight: Understanding the Heterogeneity of Myeloid Malignancies
              • Issue 5 Fall 2016
                • Clinical Trial Spotlight-Trial 12-537 Ipilimumab for Patients Who Relapse after Allogeneic Transplantation
                • Immunomodulation in Multiple Myeloma
                • PD-1 Blockade in Classical Hodgkin Lymphoma
                • Research Spotlight New Frontiers in Cellular Therapies-360 Degrees of Immuno-oncology
              • Issue 6 Spring 2017
                • Allogeneic Stem Cell Transplantation for Older Adults with Hematologic Malignancies
                • Caring for Older Adults with Multiple Myeloma
                • Case Study Managing Lymphoma in an 80-Year-Old Patient
                • Clinical Trial Spotlight Trial Number 17-049
                • Faculty Spotlight: Q&A with Eric S. Winer, MD
                • Research Spotlight: Older Adult Hematologic Malignancy Program
              • Issue 7 Fall 2017
                • Case Study CAR T-Cell Therapy for Refractory DLBCL
                • Clinical Trial Spotlight Evaluating Daratumumab in Combination with RVD
                • Clinical Trial Spotlight Trial 14-296
                • Faculty Spotlight Q and A with Oreofe Odejide MD
                • Research Spotlight CHIP and the Impact on Stem Cell Transplant Outcomes
                • The Evolving Landscape of Treatment for Acute Lymphoblastic Leukemia
              • Issue 8 Spring 2018
                • Bringing Novel Therapies to More Patients
                • Case Study Adding Venetoclax to Azacitidine
                • Dana-Farber Network
                • Faculty Spotlight Austin Kim MD
                • New Medical Oncology Chair Benjamin Ebert Leads Myeloid Malignancies Research
                • Sharing the Care of Stem Cell Transplant Patients
              • Issue 9 Fall 2018
                • Center for Prevention of Progression Clinic
                • Faculty Spotlight Zuzana Tothova MD PhD
                • Harnessing NK Cell Memory
                • Screening and Early Intervention Trials for Precursor Conditions
                • TP53-Mutated Myelodysplastic Syndrome
            • Center for Prevention of Progression
          • Stem Cell Transplant and Cellular Therapies
            • Cellular Therapies Resources
            • International Patients
            • Stem Cell Transplant Resources
        • Education & Training
        • Physician Gateway
        • Refer a Patient
          • Shared Care Hematologic Malignancies
            • Clinician Education
              • Direct Access
              • HSCT
              • Leadership
              • Physician Experience
        • Health Library
          • Articles
            • Anemia symptom management
            • Ask the cancer genetics team: inherited tendency for pheochromocytomas
            • Ask the cancer genetics team: insurance coverage
            • Ask the cancer genetics team: Lynch syndrome and aspirin
            • Ask the cancer genetics team: medical and psychological considerations of a preventive mastectomy
            • Ask the cancer genetics team: reducing cancer risk through exercise
            • Ask the cancer genetics team: reproductive options for people with Li-Fraumeni Syndrome
            • Ask the cancer genetics team: talking to children about genetic test results
            • Ask the cancer genetics team: testing and risk to insurance coverage
            • Ask the cancer genetics team: when to test children
            • Ask the expert Q and A on breast cancer
            • Ask the expert Q and A on chronic myelogenous leukemia CML
            • Ask the expert Q and A on Inflammatory Breast Cancer
            • Ask the expert: Q & A on adult primary brain tumors and brain metastases
            • Ask the expert: Q & A on brain cancer
            • Ask the expert: Q & A on breast cancer, exercise and diet
            • Ask the expert: Q & A on lung thoracic cancer
            • Ask the expert: Q & A on Lynch syndrome
            • Ask the expert: Q & A on therapies for breast cancer
            • Ask the expert: Q & A on uterine, ovarian, and cervical cancer
            • Barium enema: What to expect
            • Beyond Cancer
            • Biofeedback
            • Biopsy information for head and neck patients
            • Blood counts
            • Brachytherapy
            • Breast biopsy
            • Breast cancer screening recommendations
            • Bronchoscopy
            • Cancer and menopause
            • Cancer Conversations
            • Cancer Mythbusters
            • Cancer Mythbusters Alternative Therapies and Integrative Therapies
            • Cancer Mythbusters Brain Tumor Myths
            • Cancer Mythbusters Breast Cancer Risk
            • Cancer Mythbusters Breast Lumps and Cancer
            • Cancer Mythbusters Cancer Clinical Trials
            • Cancer Mythbusters Cancer Genetics and Prevention
            • Cancer Mythbusters Chemotherapy Myths and Misconceptions
            • Cancer Mythbusters Early Cancer Detection and Risk
            • Cancer Mythbusters Is Cancer Contagious
            • Cancer Mythbusters Is Palliative Care Only for End-of-Life Patients
            • Cancer Mythbusters Leukemia Myths
            • Cancer Mythbusters Prostate Cancer Myths
            • Cancer Mythbusters Smoking and Lung Cancer
            • Cancer Mythbusters Superfoods and Cancer
            • Cancer Mythbusters The Myth That Cancer Is a Battle
            • Cancer Mythbusters What to Know About Marijuana
            • Cancer Podcast Series
            • Cancer screening recommendations
            • Cervical Cancer and HPV
            • Cervical cancer screening recommendations
            • Cervical cone biopsy
            • Chiropractic
            • Co-Enzyme (Q10 CoQ10, Ubiquinone or Ubiquinol)
            • Colorectal cancer screening recommendations
            • Combination and High-Dose Chemotherapy for Testicular Cancer Patients
            • Constipation management
            • Coping with lymphedema
            • Dilation and Curettage
            • Exercise to decrease cancer risk
            • Exercising with lung cancer
            • For Caregivers
            • Guided imagery
            • Hair loss during cancer treatment
            • Head and neck cancers with Robert Haddad, MD
            • Head and neck oral cancer screening recommendations
            • How 'Prehabilitation' Can Benefit Cancer Patients
            • How does stem cell transplant affect the body?
            • How to Care for Your Central Line
            • How to choose a wig
            • Instruction Sheets for Imaging
            • Instructions after removal of a Hickman catheter
            • Instructions for intramuscular injection
            • Instructions for subcutaneous injection
            • Instructions to disconnect CADD pump and flush port-a-cath
            • Integrative Therapies Education Series
            • Interstitial brachytherapy
            • Laparoscopy: What you should know
            • Lung cancer screening recommendations
            • Lynch Syndrome Are You at Risk
            • Magnetic Resonance Imaging MRI
            • Mammography
            • Managing cancer-related fatigue
            • Managing chemotherapy-induced diarrhea
            • Meal Planning: Fruits and Vegetables
            • Meal Planning: Healthy Cooking Techniques
            • Mediastinoscopy
            • Medications A – Z
            • Meditation Audio Series
            • Mouth care for cancer patients
            • Nasopharyngoscopy
            • Needle aspiration
            • Nutrition and Cancer
            • Oral Chemotherapy Drug Diary
            • Oral chemotherapy fact sheet
            • Paracentesis
            • Pediatric Stem Cell Transplant FAQ
            • PEG removal
            • Photodynamic therapy
            • Physical exercise
            • Post-operative instructions following gynecologic oncology surgery
            • Post-traumatic stress and cancer
            • Preparing for your PETCT scan
            • Prescriptions for controlled substances: What you need to know
            • Preventing the flu
            • Prostate cancer screening recommendations
            • Provenge® - Frequently Asked Questions
            • Pulmonary Function Tests
            • Questions about exercise during and after cancer treatment
            • Recommended Nutrition Books
            • Recommended Nutrition Education Materials
            • Recommended Nutrition Websites
            • Recovering from your hysterectomy
            • Screening and prevention for people with a family history of colorectal cancer
            • Sentinel lymph node biopsy for breast cancer
            • Sexual Health, Intimacy, and Cancer
            • Sexual intimacy during cancer treatment
            • Skin cancer screening recommendations
            • Small Intestine Removal
            • Stem Cell Transplant Glossary
            • Stereotactic radiation transforms treatment of many lung tumors
            • Strategies and Tips for Grieving
            • Supra pubic tube
            • Symptoms of Inflammatory Breast Cancer
            • Take Control of Your Cancer Risk
            • Talking to co-workers about a cancer diagnosis
            • Tandem and ovoid brachytherapy
            • Ten thousand steps a day
            • The Science Behind Cancer
            • The Science Behind Cancer What is Immunotherapy
            • Tips for Exercising During and After Cancer Treatment
            • Tips for Managing Chemobrain
            • Tips for Managing Insomnia During Cancer Treatment
            • Tips for Managing Neuropathy
            • Triple-Negative Breast Cancer
            • Types of stem cell transplant
            • Under the Umbrella: Dana-Farber Sun Safety Education Series
            • Understanding Grief
            • Understanding upper endoscopy and colonoscopy
            • Unraveled
            • Upper GI series test
            • Voices
            • Vulvar cancer surgery: What you should know
            • Walking as exercise
            • Warm up, stretch, cool down
            • What happens during the stem cell transplant process?
            • What is a lumbar puncture?
            • What is cancer?
            • What Is Immunotherapy for Cancer?
            • What Is Lobular Breast Cancer?
            • When and how to wash your hands
            • Why are stem cell transplants performed?
          • Recipes
            • Apple Blueberry Crisp
            • Apple Spice Muesli with Blueberries and Almonds
            • Apple Spinach Salad
            • Apricot-Orange Smoothie
            • Asian Chicken and Coconut Soup
            • Autumn Apple Salad
            • Avocado-Berry Smoothie
            • Baked Haddock with Thyme
            • Baked Sweet Potato Wedges
            • Banana Breakfast Bites
            • Banana-Walnut Bread
            • Beet and Citrus Salad with White Balsamic Vinaigrette
            • Berry Walnut Oatmeal
            • Black Bean and Walnut Brownies
            • Blueberry Frozen Yogurt
            • Blueberry Pecan Pancakes
            • Blueberry Smoothie
            • Breakfast Burrito
            • Broccoli Salad
            • Butternut Squash and Bean Salad
            • Cannellini Tuna Arugula Salad
            • Carrot and Ginger Salad
            • Carrot Ginger Slaw
            • Carrot Ginger Soup with Spicy Shrimp
            • Carrot Lemon Apple Juice
            • Carrot Muffins
            • Cheesy Chili Mac
            • Chicken Stir-Fry
            • Chicken Vegetable Kabobs
            • Chickpea Blondies
            • Chocolate Chia Seed Pudding
            • Chocolate Peanut Butter and Banana Shake
            • Chocolate Yogurt Mousse
            • Chocolate-Banana Breakfast Quinoa
            • Corn Avocado and Tomato Salad
            • Cowboy Caviar
            • Cranberry Apple Oat Muffins
            • Creamy Butternut Squash Soup
            • Creamy Pumpkin Pudding
            • Creamy Tomato Soup
            • Cucumber Soup
            • Cucumbers with Ginger Vinaigrette
            • Early Autumn Frittata with Fall Salad
            • Egg Pesto Breakfast Sandwich
            • Eggplant Ricotta Bake
            • Escabeche Sweet and Sour White Fish
            • Flavorful meals without the salt
            • Gazpacho
            • Ginger, Avocado, Shrimp Bowl
            • Glazed Butternut Squash
            • Green Tea Smoothie
            • Grilled Chicken Portobello Salad
            • Grilled Pineapple
            • Hummus Avocado and Roasted Eggplant Wrap
            • Infused Water
            • Inside Out Tacos
            • Irish Rebel Stew
            • Irish Soda Bread
            • Lentil Chili
            • Mango Coconut Overnight Oats
            • Mediterranean Barley Almond Salad
            • Mediterranean Tuna Salad
            • Millet Salad with Avocado Edamame and Mandarin Oranges
            • Minty Tomato and Watermelon Feta Salad
            • Mixed Berry Smoothie
            • No-Bake Pumpkin Oatmeal Cookies
            • Oatmeal Energy Bites
            • Orange Cranberry Chicken
            • Parchment Wrapped Citrus Salmon
            • Peanut Butter Energy Bites
            • Plant-Powered Chickpea Salad
            • Poached Apples with Spices
            • Poached Pears and Spices
            • Potato Leek Soup
            • Pumpkin and White Bean Hummus
            • Pumpkin Bread
            • Pumpkin Mousse with Oat and Pecan Crumble
            • Pumpkin Pear Waffles
            • Pumpkin Soup
            • Pureed Squash and Ginger Dipping Sauce
            • Quinoa Salad with Black Beans and Peaches
            • Red Lentil Soup with Lemon
            • Red Pepper Farro Salad
            • Red Rice Fiesta Beans Salad
            • Roasted Artichokes with Parsley and Garlic
            • Roasted Asparagus with Parmesan Cheese
            • Roasted Butternut Squash
            • Roasted Cauliflower with Lemon and Garlic
            • Roasted Corn Salad
            • Roasted Sweet Potato and Chipotle Creamy Soup
            • Roasted Sweet Potato Slices
            • Roasted Vegetable Quinoa Salad
            • Rosemary and Veggie Frittata
            • Salmon Burgers
            • Sauteed Green Beans
            • Scallop Stir-Fry
            • Seafood Bisque
            • Sesame Broccoli
            • Spice Protein Pancakes
            • Spinach and Artichoke Egg Souffle
            • Spinach Strawberry Walnut Salad
            • Summer Vegetable Omelet
            • Super Food Sushi
            • Sweet Potato and Dried Cranberry Cookie
            • Tinola Ginger and Chicken Soup
            • Tofu Stir-Fry
            • Tomato, Basil, and Mozzarella Salad
            • Turkey Meatloaf
            • Vegetable Egg Strata
            • Vegetarian Chili
            • Vegetarian Jambalaya
            • Waldorf Dandelion Salad
            • Walnut Crusted Trout Fillets
            • Wheat Germ Muffins with Blueberries
            • White Turkey Chili
            • Wild Salmon Burgers
            • Winter Squash Crostini
            • Yogurt Protein Smoothie
            • Zucchini Bread
            • Zucchini Carrot Oatmeal Muffins
          • Videos
            • Ask the Expert: Cervical Cancer Videos
            • Breast Cancer Surgery: Lumpectomy vs. Mastectomy
            • Breast cancer treatment: Aromatase inhibitors and tamoxifen
            • Cancer Video Webchat Series
            • Choosing a Wig
            • Do African-Americans need more vitamin D?
            • Does Testicular Cancer Treatment Affect Sexual Function?
            • Dr. George Demetri Discusses Liposarcoma
            • Eating Well During Cancer
            • How Does Testicular Cancer Treatment Affect Fertility?
            • How Is Immunotherapy Used to Fight Cancer?
            • How Is Testicular Cancer Diagnosed?
            • How Is Testicular Cancer Treated?
            • How to Change the Dressing on Your Hickman Catheter
            • How to Disconnect Your Port at Home
            • How to Flush Your Central Line and Change the Cap
            • How to Gain Weight after Cancer Treatment
            • How to Lose Weight after Cancer Treatment
            • Lebed Method: Simple exercises for cancer patients
            • Lung Cancer Webchat: What You Need to Know About Research, Treatment, and Prevention
            • Lynch Syndrome Program
            • Managing Symptoms during Chemotherapy Treatment
            • Multiple Myeloma Patient Symposium Video Presentations
            • Radiation Therapy for Breast Cancer: Deep Inspiration Breath-Hold
            • Role of diet in women’s cancers
            • Role of obesity and exercise in women’s cancers
            • Sex after Cancer: A Journey of Renewal for Women
            • Signs and Symptoms of Breast Cancer
            • Starting Chemotherapy: What to Expect
            • Stem Cell Transplant in Children
            • The Cancer-Nutrition Link
            • Tips for Tying a Headscarf
            • Vitamins and Supplements – The Benefits of Food First
            • Webchat with Dr. Matulonis: The Latest in Ovarian Cancer Treatment
            • Webchat: Best Foods and Diet for Cancer Treatment and Survivorship
            • Webchat: Choosing a Clinical Trial for Metastatic Breast Cancer
            • Webchat: How to Cope with a Breast Cancer Diagnosis
            • Webchat: How to Eat Healthfully – and Why We Should
            • Webchat: Life after Childhood Cancer Treatment
            • Webchat: Melanoma – What’s the Latest?
            • Webchat: New Therapies and Research for Lymphoma
            • Webchat: Parenting during Cancer Treatment
            • Webchat: The Latest in Brain Tumor Research and Treatment
            • Webchat: The Latest in Cervical Cancer Treatment and Research
            • Webchat: The Latest in Colon Cancer Prevention
            • Webchat: The Latest in Multiple Myeloma, Leukemia, and Other Blood Cancers
            • Webchat: The Latest in Precision Medicine and Lung Cancer
            • Webchat: The Latest in Prostate Cancer Research and Treatment
            • Webchat: What's New in Pediatric Brain Tumor Treatment?
            • What is ALL?
            • What is DCIS?
            • What is Inflammatory Breast Cancer?
            • Why a Balanced, Plant-Based Diet Is Good for Your Health
            • Why You Need a Health Care Proxy
            • Young Adults Coping with Cancer
        • How You Can Help
          • Events
            • Organize a Fundraising Event
            • Participate in a Fundraising Event
              • Dana-Farber Marathon Challenge
                • Claudia Adams Barr Program
              • Dana-Farber Palm Beach
                • Events
                  • Annual Discovery Celebration
                  • Breakfast with the Doctors
                  • Cocktails and Conversation with Our Doctors
                  • Pre-Celebration Dinner
                • Levels of Giving
            • Support a Participant or Event
          • Get Involved
            • Behind the Breakthroughs
            • Corporate Engagement
              • Councils
                • Dana-Farber Leadership Council
                • Donate Blood and Platelets
                  • About
                  • Blood Drive Calendar
                  • FAQs
                  • The Krafts and Patriots
                  • What to Expect
                • Donate Bone Marrow and Stem Cells
                  • Calendar of Drives
                  • Donate
                  • FAQs
                  • Host a Drive
                • Friends of Dana-Farber Cancer Institute
                  • Become a Friend
                  • Board and Bios
                    • Alexandra Slote
                    • Amye Kurson-Collins
                    • Andrea Segel
                    • Anita Fink
                    • Barbara Lapp
                    • Betsy Cohen
                    • Cristina Sage Peters
                    • Dana Gerson Unger
                    • Elaine Zouzas Thibault
                    • Gabrielle Baron
                    • Gina Morda
                    • Heather Gelchion
                    • Helen Lin
                    • Jamie Monovoukas
                    • Jane Savas
                    • Jayne Bennett Friedberg
                    • Jean F Pearlstein
                    • Jean Speare Canellos
                    • Jen Cunningham Butler
                    • Jill Papagni
                    • Judith O’Karma McCaffrey
                    • Julie Kae
                    • Kathleen Cook
                    • Kim Fauria
                    • Lauren Emily Frei
                    • Leeann To Ouimet
                    • Lesley Ann Prowda
                    • Louise Shivek
                    • Lucy Santos
                    • Marci Noller
                    • Marilyn Wolman
                    • MaryBeth Finn
                    • Melanie A. Conroy
                    • Micki Hirsch
                    • Sarah Bowler
                    • Seth Andrea McCoy
                    • Susan Mendoza Friedman
                    • Suzanne Bloomberg
                    • Suzanne Chapman
                    • Tobey Oresman
                    • Trudi Feinstein
                  • Cards
                  • Donate to the Friends
                  • Events
                    • Dinner with Friends
                    • Saks Key to the Cure
                  • Programs
                    • Art Program
                    • Patient Gift Bags
                • Legislative Action Network
                  • Visiting Committee
                    • Volunteer
                      • FAQs
                      • How to Apply
                      • Information
                      • Opportunities
                      • Requirements
                  • Shop
                    • State Mailing Information
                    • Ways to Give
                      • Corporate and Employee Giving
                        • Employee Giving
                          • Other Ways to Give
                          • Start Today
                        • President's Circle Corporate Leaders
                      • Create Your Own Fundraising Page
                      • Foundation Giving
                      • Give Monthly
                      • Giving Day
                      • Giving Societies
                        • Breakthrough Society
                          • Dana-Farber Society
                            • History
                            • Membership
                            • Society News
                          • Presidents Circle
                          • Make a Memorial or Tribute Gift
                          • Naming and Funding Opportunities
                            • People and Programs
                              • Endowed Chairs
                              • Endowed Professorships
                            • Places and Spaces
                              • Gene Display
                              • The Imagine Display
                              • Zebrafish Display
                          • Tax-Efficient Gifts
                            • Donor Advised Funds
                            • Give Stock
                            • IRA Gifts
                              • Resources for Advisors
                        • Newsroom
                        • Physician Star Ratings at Dana-Farber Cancer Institute
                        • Privacy Policy
                        • Research
                          • Clinical Trials
                            • Clinical Trials FAQ for Pediatric Patients
                            • FAQ
                            • Find a Clinical Trial
                          • Core Facilities
                          • Departments Centers and Labs
                            • Departments and Centers
                              • Arthur and Linda Gelb Center for Translational Research
                                • Collaboration & Contact
                                • FAQ
                                • Services
                                • Team
                              • Blood Cancer Research Partnership
                                • Clinical Trials
                                • Leadership and Investigators
                                • Participating Sites
                              • Cancer Care Equity Program
                                • About the Program
                                • Events
                                  • Cancer Research Disparities Symposium Highlights
                                • Our Team
                              • Center for Community-Based Research
                              • Center for Prevention of Progression of Blood Cancers
                                • Department of Cancer Biology
                                  • Cancer and the Nervous System
                                  • Cancer Biology Faculty
                                  • Chemical Biology
                                  • Energy Homeostasis
                                  • Signaling Mechanisms
                                  • Structural Biology
                                  • Systems Biology
                                • Department of Cancer Immunology and Virology
                                  • About
                                  • Basic Immunological Mechanisms
                                  • Cancer Immunology and Immunotherapy
                                  • Cancer Immunology Working Group
                                  • Join Our Team
                                  • Our Team
                                  • Viral Immunology
                                • Department of Cellular Therapies Quality Assurance
                                  • Accreditations
                                  • Related Reading
                                  • Services
                                  • Team Leadership
                                • Department of Data Science
                                  • cBio Center
                                  • cBioPortal
                                • Department of Imaging
                                  • Contact Us
                                  • Facilities
                                  • Our Team
                                  • Training
                                • Department of Medical Oncology
                                  • Clinical Activities
                                  • Educational and Fellowship Activities
                                  • Research Activities
                                • Department of Oncologic Pathology
                                  • Faculty
                                • Department of Pediatric Oncology
                                  • Drug Discovery and Cancer Biology
                                  • Hematologic Malignancies
                                  • Neuro-Oncology
                                  • Population Sciences
                                  • Solid Tumors
                                • Department of Psychosocial Oncology and Palliative Care
                                  • Contact Us
                                  • Education
                                  • Research
                                    • Pediatric Palliative Care Research Network
                                • Department of Radiation Oncology
                                • Phyllis F Cantor Center for Research in Nursing and Patient Care Services
                                  • Current Research
                                  • Staff Profiles
                                  • Supporting Evidence-Based Practice
                                • Program in Regulatory Science
                                  • Clinical Trial Designs
                                  • Our Team
                              • Integrative Research Centers
                                • Blais Proteomics Center
                                • Center for Biomedical Imaging in Oncology
                                • Center for BRCA and Related Genes
                                  • About BRCA and Related Genes
                                  • Clinical Trials
                                  • Contact Us
                                  • For Providers Referring Patients
                                  • Our Research
                                  • Our Team
                                • Center for Cancer Genomics
                                  • Bioinformatics
                                  • CSIR Biopsy Collections
                                  • Our Services
                                  • Our Team
                                  • Profile
                                  • Research and Development
                                • Center for Cancer Systems Biology
                                • Center for Clinical and Translational Research
                                • Center for DNA Damage and Repair
                                  • Our Team
                                  • Publications
                                • Center for Functional Cancer Epigenetics
                                • Center for Patient Derived Models
                                  • Brain Tumor Models
                                  • Characterization of Patient Derived Models
                                  • Clinical Data Annotation
                                  • Hematologic PDX Models
                                  • Integration of Model Creation in Clinical Trials
                                  • Meet the CPDM Team
                                  • Models for Immuno-Oncology
                                  • New Patient Derived Model Creation
                                  • Novel Method Development
                                  • Ordering Patient Derived Models
                                  • Pediatric Tumor PDX and Spheroid Models
                                  • SMR Technology
                                  • Solid Tumor PDX Models
                                • Center for Personal Cancer Vaccines
                                  • Clinical Trials and Discovery Science
                                  • Contact Us
                                  • Our Team
                                • Chemical Biology Program
                                  • About
                                  • Basic Chemistry and Chemical Biology
                                  • Interest Groups
                                  • Medicinal Chemistry
                                  • Our Team
                                  • Protein-Protein Interactions
                                  • Small Molecule Probes, Inhibitors and Degraders
                                  • Structural Biology and Proteomics
                                • Hale Family Research Center
                                • McGraw Patterson Center for Population Sciences
                                  • Contact Us
                                  • Faculty
                                  • Our Centers
                                  • Research Support
                                • Perini Family Survivors Center
                                • Robert and Renee Belfer Center for Applied Cancer Science
                              • Lab Websites
                            • Featured Research
                              • Count Me In
                              • Parker Institute for Cancer Immunotherapy
                                • Researchers at Dana-Farber
                              • Profile
                            • Innovations
                              • Areas of Research
                              • Available Technologies
                              • Collaboration Opportunities
                                • Novartis DDTRP
                              • Contact Us
                              • Our Process
                              • Our Team
                              • Research Faculty
                            • Our Researchers
                              • For Postdocs
                                • Helen Gurley Brown Presidential Initiative
                                • Joining Dana-Farber
                                • Postdoctoral and Graduate Student Association
                                • Resources
                              • Research Administration
                                • Disclosure of Dana-Farber Innovations
                                • Research Integrity
                            • Supporting Dana-Farber Researchers
                            • What Distinguishes Dana-Farber Research
                          • Resources
                          • Social Media Policy
                          • Terms of Use
                          • Dana-Farber Spotlight
                          • For Journalists
                          • Insight Blog
                          • News Coverage
                            • News Releases
                              • 2007
                                • 2008
                                  • 2009
                                    • 2010
                                      • 2011
                                        • 2012
                                          • 2013
                                            • 2014
                                              • 2015
                                                • 2016
                                                  • 2017
                                                    • 2018
                                                      • AAAS and Dana-Farber Cancer Institute announce 2018 Fellows
                                                      • After 60 years, scientists uncover how thalidomide produced birth defects
                                                      • Ann Partridge honored as the 2018 AACR Outstanding Investigator for Breast Cancer Research
                                                      • Aromatase inhibitor plus ovarian suppression yields benefit in high-risk premenopausal breast cancer patients
                                                      • Blood test shows potential for early detection of lung cancer
                                                      • Choice of surgery may affect quality of life for young breast cancer survivors
                                                      • Cognitive decline prevalent among elderly patients with hematologic cancers, study finds
                                                      • Combination immunotherapy yields high survival rate in advanced melanoma
                                                      • Compounds that mimic host cell receptors show promise in protecting against HIV-1 infection, studies show
                                                      • Comprehensive map of altered gene pathways in dozens of cancer types will guide research in precision cancer medicine
                                                      • Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Center for Protein Degradation
                                                      • Dana-Farber Cancer Institute appoints six new members to Board of Trustees
                                                      • Dana-Farber Cancer Institute earns “LGBTQ Healthcare Equality Leader” designation in HRC Foundation’s Healthcare Equality Index
                                                      • Dana-Farber Cancer Institute Faculty presenting at American Association of Cancer Research Annual Meeting 2018
                                                      • Dana-Farber Cancer Institute Faculty Recognized at 2018 AACR Annual Meeting
                                                      • Dana-Farber Cancer Institute ranks #7 on 2018 Forbes Best Mid-Size Employers List
                                                      • Dana-Farber Cancer Institute to develop an outpatient hospital satellite at Patriot Place in Foxborough
                                                      • Dana-Farber Cancer Institute, Novartis and Harvard team up to develop next generation biomaterial systems to deliver immunotherapies
                                                      • Dana-Farber faculty receives ESMO Translational Research Award
                                                      • Dana-Farber launches Chinese-language website
                                                      • Dana-Farber launching new research initiative to improve patient reported outcomes
                                                      • Dana-Farber Medical Oncology Chair named Howard Hughes Medical Institute Investigator
                                                      • Dana-Farber researcher is a new Allen Distinguished Investigator
                                                      • Dana-Farber researcher is recipient of prestigious investigator award from National Cancer Institute
                                                      • Dana-Farber researcher receives New Innovator Award for Highly Innovative Research from NIH
                                                      • Dana-Farber researcher To Co-Lead Stand Up To Cancer's New Approach to Multiple Myeloma
                                                      • Dana-Farber researchers present findings at ASCO annual meeting
                                                      • Dana-Farber researchers report clinical trial results in treatment of leukemia and lymphoma
                                                      • Dana-Farber scientists find new drug targets in aggressive cancers
                                                      • Dana-Farber scientists to present new research on improving outcomes in stem cell transplantation for myeloid cancers
                                                      • Dana-Farber scientists to present research on myeloma progression from precursor conditions and novel approaches to treatment
                                                      • Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
                                                      • Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive year
                                                      • Dana-Farber/Brigham and Women’s Cancer Center offers CAR T-cell therapy Kymriah™, now approved for lymphoma
                                                      • Dana-Farber’s bank of patient-derived tumor xenografts gets major boost from Novartis
                                                      • Dana-Farber’s Sun Safety/Skin Cancer Prevention Program visiting local beaches this summer
                                                      • Discovery suggests new strategy for attacking high-profile but elusive target in cancer
                                                      • Dual kinase inhibitor shows promise in multiple cancer types in phase I trial
                                                      • Due to winter storm Grayson, urgent need for blood and platelets for patients at Dana-Farber and Brigham and Women's Hospital
                                                      • Eric Winer, MD awarded the 2018 Susan G. Komen Brinker Award for Scientific Distinction in Clinical Research
                                                      • Exercise shown to reduce numbers of circulating tumor cells in patients with colon cancer
                                                      • Exercise-related hormone irisin found to target key bone cells
                                                      • Expanded Lab Facility at Dana-Farber aids personalized medicine efforts
                                                      • Fast-growing organoid models of ovarian cancer could aid rapid drug treatment selection
                                                      • Genetic markers may predict which melanoma patients benefit from immunotherapy drug
                                                      • Genomic analysis unravels complexities of the most common form of lymphoma and enables personalized treatment
                                                      • Give blood at Patriots Training Camp to help patients at Dana-Farber and Brigham and Women’s
                                                      • Global Cancer Trial Sets New Standard for Post-Surgery Chemotherapy
                                                      • Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning and eliminates cancer spread in mouse study
                                                      • HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer
                                                      • Immunotherapy/PARP inhibitor combination produces ovarian cancer remissions at much higher rate than either drug alone, phase I/II clinical trial shows
                                                      • In multiple myeloma, different types of blood biopsies match up well with bone marrow tests
                                                      • James Terwilliger named as Executive Vice President and Chief Operating Officer at Dana-Farber Cancer Institute
                                                      • Laurie H. Glimcher, MD receives the 2018 American Association of Immunologists Lifetime Achievement Award
                                                      • Laurie H. Glimcher, MD, recognized as one of the 50 Most Influential Physician Executives and Leaders by Modern Healthcare
                                                      • Local television reporter Victoria Warren to join Dana-Farber Cancer Institute
                                                      • Loss of peripheral fat and muscle occurs early in development of pancreatic cancer
                                                      • Mechanism for resistance to immunotherapy treatment discovered
                                                      • Melany Duval Named New Senior Vice President, Development at Dana-Farber Cancer Institute
                                                      • Model can predict success of treatments that manipulate the gut microbiota
                                                      • Molecular “hijacking” of a gene-regulating protein complex triggers rare sarcoma
                                                      • Moritz Kircher, MD, PhD, named Chair of Dana-Farber Department of Imaging and Radiology
                                                      • Neoantigen vaccine spurs immune response in glioblastoma
                                                      • New gene therapy strategy for sickle cell disease shows early promise in humans
                                                      • New research from Dana-Farber highlights quality-of-life issues facing breast cancer survivors following surgery
                                                      • Non-coding DNA reveals a route by which advanced prostate cancer resists treatment
                                                      • Novel diabetes drugs sensitize cancer cells to chemotherapy agents
                                                      • Pancreatic Cancer Collective awards Dana-Farber Cancer Institute researchers “New Therapies Challenge” grant
                                                      • Patients and researchers team up to fight metastatic prostate cancer
                                                      • Philips and Dana-Farber operationalize and scale Clinical Pathways
                                                      • Pioneering Hematologist to Receive 2018 Nemmers Prize in Medical Science
                                                      • Placebo improves cancer-related fatigue in cancer survivors even though they know they’re taking an inactive pill, study finds
                                                      • Prostate cancer scoring method may underestimate mortality risk in black men
                                                      • Public awareness of cancer drug shortages is lacking, but most would want to know about drug substitutions if they were patients, study finds
                                                      • Real-time DNA sequencing in advanced pancreatic cancer can guide precision medicine treatment
                                                      • Research shows that diet can lower risk of recurrence in stage III colon cancer
                                                      • Researchers launch screening study of individuals at high risk of multiple myeloma
                                                      • Researchers, cancer patients, and philanthropists launch Count Me In, a new model of patient-partnered research to speed progress against cancer
                                                      • Scientists create powerful, rapid system for degrading proteins
                                                      • Scientists uncover “long tail” of nearly 100 genes mutated in prostate cancer
                                                      • Single-cell analysis reveals how melanoma cells resist immunotherapy
                                                      • Small genetic script causes drug resistance in some ovarian cancers
                                                      • Study findings in metastatic HPV-linked head and neck cancer may help guide treatment
                                                      • Study finds inherited gene variants in 10 percent of pancreatic cancer patients
                                                      • Study finds melanoma biomarkers predicting checkpoint blocker response
                                                      • Study identifies predictors of immunotherapy response in head and neck cancer
                                                      • Study of genomic changes in multiple myeloma may lead to new approaches to treating early, smoldering myeloma
                                                      • Study provides first systematic survey of metabolites across tumor types
                                                      • Study resolves decades-old mystery about the most commonly mutated gene in cancer
                                                      • Study reveals how tumor microenvironment sabotages immune T cells
                                                      • Study reveals that many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable to do so
                                                      • Study sheds new light on mechanism of breast cancer treatment resistance
                                                      • Study shows PARP inhibitor drugs rouse immune system attack on some ovarian cancers
                                                      • Study uncovers key parts of mechanism for activating T cells to fight cancer and other diseases
                                                      • Teams from Dana-Farber and Boston Children’s Hospital win Moonshot grants to probe childhood cancers
                                                      • Three Dana-Farber researchers awarded new grant to accelerate multiple myeloma research
                                                      • Two Dana-Farber Cancer Institute faculty members are inductees in the 2018 Giants of Cancer Care® by OncLive
                                                      • Two Dana-Farber faculty elected to prestigious National Academy of Medicine
                                                      • Unlocking Cancer’s Secrets Using the Social Networks of Cells
                                                      • Venetoclax combination approved for elderly AML
                                                    • 2019
                                                      • “Stapled” antimicrobial peptides could combat antibiotic resistance
                                                      • Adult cells maintain a virtually complete molecular “memory” of their embryonic origins, researchers find
                                                      • AI tool identifies cancer outcomes using radiology reports
                                                      • Backed by Dana-Farber research, FDA approves new drug combination for treating advanced kidney cancer
                                                      • Beth Mittendorf, MD, PhD will lead new Stand Up To Cancer research team
                                                      • Black men less likely than nonblack patients to adopt active surveillance for low-risk prostate cancer
                                                      • Cape Cod Hospital to join Dana-Farber Cancer Care Collaborative
                                                      • Cause of drug resistance in a type of intestinal tumors identified
                                                      • Chronic insomnia can be cured in cancer survivors with a basic, one-session sleep education class, study finds
                                                      • Cigall Kadoch, PhD, chosen for 2019 Wachtel Cancer Research Prize
                                                      • Clinical trial underscores promise of immunotherapy, in combination with second drug, for ovarian cancer
                                                      • Combination of PARP inhibitor and targeted therapy significantly outperforms PARP inhibitor alone in patients with chemotherapy-resistant ovarian cancer
                                                      • Dana-Farber and the Broad Institute launch new patient partnered research initiative
                                                      • Dana-Farber announces $20 million gift from the Saverin Family for metastatic breast cancer research
                                                      • Dana-Farber Cancer Institute and the Jimmy Fund debut new visual identity
                                                      • Dana-Farber Cancer Institute earns “LGBTQ Health Care Equality Top Performer” Designation in HRC Foundation’s Healthcare Equality Index
                                                      • Dana-Farber Cancer Institute faculty elected to National Academy of Medicine
                                                      • Dana-Farber Cancer Institute Faculty named AAAS 2019 Fellows
                                                      • Dana-Farber Cancer Institute faculty recognized as 2019 ASCO leaders in cancer care
                                                      • Dana-Farber Cancer Institute is awarded its fourth consecutive designation as a Magnet® organization for excellence in nursing practice and patient care
                                                      • Dana-Farber Cancer Institute launches new national advertising campaign
                                                      • Dana-Farber Cancer Institute receives $5 million gift to create the Edward P. Evans Center for Myelodysplastic Syndromes
                                                      • Dana-Farber Cancer Institute Receives Largest Gift Ever, a Record-Breaking $63 Million
                                                      • Dana-Farber Cancer Institute researcher awarded funding from Chan Zuckerberg Initiative for Open Source Software Project
                                                      • Dana-Farber Cancer Institute researchers among highly cited researchers according to 2019 Web of Science Group list
                                                      • Dana-Farber Cancer Institute researchers win Grand Challenge funding from Cancer Research UK
                                                      • Dana-Farber faculty to present research at AACR Annual Meeting 2019
                                                      • Dana-Farber joins with leading Boston teaching hospitals and universities in announcing new center for advanced biological innovation and manufacturing
                                                      • Dana-Farber named one of the most noteworthy MA companies and non-profits led by women
                                                      • Dana-Farber opening new center for patients with common syndrome that can lead to cancer
                                                      • Dana-Farber opens Center for the Prevention of Progression clinic
                                                      • Dana-Farber opens new clinical trials for patients with endometrial cancer
                                                      • Dana-Farber physician-scientist David Braun honored as Next Gen Innovator
                                                      • Dana-Farber Researcher awarded 2019 Paul Marks Prize for Cancer Research
                                                      • Dana-Farber researcher awarded Victoria Mock New Investigator Award
                                                      • Dana-Farber researcher elected to 2019 Class of Fellows of the AACR Academy
                                                      • Dana-Farber researcher is one of three young scientists awarded 2019 Michelson Prize
                                                      • Dana-Farber researcher selected to join the Pew Scholars Program
                                                      • Dana-Farber researcher to lead team using machine learning to identify high-risk pancreatic cancer populations
                                                      • Dana-Farber researchers present findings in more than 70 research studies at ASCO annual meeting 2019
                                                      • Dana-Farber researchers to present more than 40 studies at 2019 ASH Annual Meeting
                                                      • Dana-Farber scientists and associates receive major grant from Gray Foundation for research into BRCA-related cancers
                                                      • Dana-Farber scientists present promising findings in multiple myeloma at ASH Annual Meeting
                                                      • Dana-Farber to expand services by uniting locations and opening new site in Merrimack Valley
                                                      • Dana-Farber wins additional funding to develop human cancer models
                                                      • Dana-Farber/Boston Children's nation's #1 pediatric cancer program
                                                      • Dana-Farber/Brigham and Women’s Cancer Center Offers Novel MRI-Guided Radiation Therapy for Cancer Treatment
                                                      • Dana-Farber/Brigham and Women’s Cancer Center receives largest individual gift for glioblastoma research
                                                      • Discovery of a New Immune Process Could Lead to Better Pain Treatments
                                                      • Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence
                                                      • Drug combination may become new standard treatment for advanced kidney cancer
                                                      • Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
                                                      • Eric Winer, MD honored with Jill Rose Award by Breast Cancer Research Foundation
                                                      • Exercise associated with benefit to patients with advanced colorectal cancer
                                                      • Exposure to second-hand e-cigarette aerosols increasing among young people, Dana-Farber study finds
                                                      • Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant, research shows
                                                      • Geoffrey Shapiro receives cancer drug development award from the International Congress on Targeted Anticancer Therapies
                                                      • High doses of 60-plus year-old chemotherapy drug found to spur immune system attack on lymphoma
                                                      • High-dose vitamin D shows benefit in patients with advanced colorectal cancer
                                                      • Identifying More Pancreatic Cancer Gene Mutations With Mandatory Genetic Testing, Counseling
                                                      • Inherited pancreatic cancer risk mutation identified
                                                      • Kevin Haigis to become Chief Research Officer at Dana-Farber Cancer Institute
                                                      • Laurie H. Glimcher elected to membership of the American Philosophical Society
                                                      • Long-term marijuana smoking linked to increased pulmonary disease in HIV-positive men
                                                      • Loss of a DNA repair system creates a unique vulnerability in many cancer types
                                                      • More than 115 Dana-Farber-affiliated physicians recognized as Top Doctors
                                                      • Myles Brown, MD receives 2019 AACR Distinguished Lectureship in Breast Cancer Research award
                                                      • New blood test capable of detecting multiple types of cancer
                                                      • New center addresses alarming increase in colorectal cancer rates among young adults
                                                      • New England Cancer Specialists to join Dana-Farber Cancer Care Collaborative
                                                      • New study on Serious Illness Care Program underscores significant benefit of more, better, and earlier conversations between clinicians and patients
                                                      • New targeted drugs show promise in patients with advanced HER2-positive breast cancer in two clinical trials
                                                      • New technique to determine protein structures may solve biomedical puzzles
                                                      • Patterns of chronic lymphocytic leukemia growth identified
                                                      • Personalized vaccine to be tested for the first time in patients with kidney cancer
                                                      • Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
                                                      • Radiation Treatment Increases Cardiac Risk for Lung Cancer Patients
                                                      • Researchers Awarded $1 Million to Study Optimal Use of Radioactive Drugs for Prostate Cancer Therapy
                                                      • Researchers devise a progression risk-based classification for patients with asymptomatic Waldenström macroglobulinemia
                                                      • Researchers pinpoint why lymphoma patients may become resistant to specific therapy, identify strategy to overcome it
                                                      • Resistance to immune checkpoint blocker drug linked to metabolic imbalance
                                                      • Scientists create molecular tool to remove toxic protein from nerve cell models of dementia
                                                      • Scientists identify genes tied to increased risk of ovarian cancer
                                                      • Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders
                                                      • Small molecule inhibitor shows clinical activity in lung and colorectal cancer patients
                                                      • Statement on Medical Deferred Action Program - August 31, 2019
                                                      • Study finds racial disparities in culturally competent cancer care
                                                      • Study finds upsurge in ‘active surveillance’ for low-risk prostate cancer
                                                      • Study of rare ovarian cancer sheds light on epigenetic cancer process
                                                      • Study reveals intersection of sexual orientation and demographic factors in vulnerability to tobacco ads
                                                      • Study shows benefit of PARP inhibitor for some ovarian cancer patients
                                                      • Targeted therapy proves effective against aggressive rare blood cancer
                                                      • Timing of immunotherapy nearly doubles survival rate in brain cancer patients
                                                      • T-Mobile CEO John Legere delivers $4.5 million gift to Dana-Farber Cancer Institute
                                                      • Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma, study finds
                                                      • Two Dana-Farber physician scientists receive 2019 Clinical Scientist Development Award
                                                      • U.S. District Court rules Dana-Farber scientist is an inventor on six critical immunotherapy patents
                                                      • U.S. News & World Report Names Dana-Farber/Brigham and Women’s Cancer Center Among Best in Cancer
                                                      • Unusual mechanism of CDK4/6 inhibitor resistance found, may be reversible
                                                      • Use of venetoclax in reduced-intensity transplant conditioning regimen in patients with high-risk myeloid cancers shows promise in early trial
                                                      • Walking speed points to future clinical outcomes for older patients with blood cancers
                                                      • William G. Kaelin, MD, of Dana-Farber Cancer Institute wins 2019 Nobel Prize
                                                      • Women leaders raise over $250,000 for women’s cancers research at Dana-Farber and hear about latest in early detection and prevention
                                                    • 2020
                                                      •  Eric P. Winer elected ASCO President for term starting in June 2022
                                                      • A case of reverse development: Dana-Farber scientists solve long-debated puzzle of how the intestine heals itself
                                                      • Adding checkpoint inhibitor to chemotherapy improves responses without negatively impacting quality of life in patients with early-stage breast cancer
                                                      • Biomarker Test Highly Accurate in Detecting Early Kidney Cancer
                                                      • Boston Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital Formalize Cancer Clinical Trial Collaboration
                                                      • Breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot
                                                      • CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
                                                      • Cigall Kadoch, PhD, to receive 2020 AACR Award for Outstanding Achievement in Basic Cancer Research
                                                      • Circulating tumor DNA indicates increased risk of relapse after stem cell transplant in patients with diffuse large B-cell lymphoma
                                                      • Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer
                                                      • Dana-Farber announces Center for Salivary and Rare Head and Neck Cancers
                                                      • Dana-Farber Cancer Institute and Quest Diagnostics collaborate to identify the prevalence of COVID-19 in individuals with precursor to multiple myeloma
                                                      • Dana-Farber Cancer Institute and the Jimmy Fund Establish Emergency Response Fund
                                                      • Dana-Farber Cancer Institute at the top of the 2020 Top 100 Women-Led Businesses in Massachusetts
                                                      • Dana-Farber Cancer Institute earns “LGBTQ Health Care Equality Leader” Designation in Human Rights Campaign Foundation’s Healthcare Equality Index
                                                      • Dana-Farber Cancer Institute faculty recognized as 2020 ASCO leaders in cancer research and care
                                                      • Dana-Farber Cancer Institute partners with the Prostate Cancer Foundation to advance prostate cancer treatment for our nation's veterans
                                                      • Dana-Farber Cancer Institute provides state-of-the-art oncology support services to Kronos employees through new company benefit
                                                      • Dana-Farber Cancer Institute to establish Benderson Family Program for triple-negative breast cancer
                                                      • Dana-Farber Cancer Institute to Establish Chen-Huang Center for EGFR Mutant Lung Cancers
                                                      • Dana-Farber Cancer Institute to Establish Riney Family Multiple Myeloma Initiative
                                                      • Dana-Farber collaborates with Mass. Eye and Ear to rebuild damaged corneas using patients’ own stem cells for first time in United States
                                                      • Dana-Farber faculty member Myles Brown, MD elected to the National Academy of Medicine
                                                      • Dana-Farber faculty recognized with AACR 2020 Team Science Awards
                                                      • Dana-Farber joins thousands of top U.S. hospitals encouraging everyone to #MaskUp
                                                      • Dana-Farber launches new Center for the prevention and treatment of BRCA-related cancers
                                                      • Dana-Farber leader, Laurie H. Glimcher, is recipient of public service award
                                                      • Dana-Farber leader, Laurie H. Glimcher, MD, named to Stand Up To Cancer Scientific Advisory Committee
                                                      • Dana-Farber nurse practitioner honored by American Cancer Society
                                                      • Dana-Farber opens clinical trial to evaluate simple blood test for many types of cancer
                                                      • Dana-Farber opens new facility in Merrimack Valley
                                                      • Dana-Farber President & CEO Emeritus receives ASH Award for Leadership in Promoting Diversity
                                                      • Dana-Farber research supports new indication for a prostate cancer drug, which has received FDA approval
                                                      • Dana-Farber research team awarded Pancreatic Cancer Collective “New Therapies Challenge” grant
                                                      • Dana-Farber Researcher awarded for review paper on racial disparities in survival in children with Acute Lymphoblastic Leukemia
                                                      • Dana-Farber researcher awarded Victoria Mock New Investigator Award
                                                      • Dana-Farber researcher receives highest honor from Society for Immunotherapy of Cancer
                                                      • Dana-Farber researchers present key studies at ASCO annual meeting
                                                      • Dana-Farber scientists bring experience from SARS and MERS outbreaks to aid COVID-19 research
                                                      • Dana-Farber study advances understanding of rare sarcoma
                                                      • Dana-Farber to offer first CAR T-cell therapy for mantle cell lymphoma following FDA approval
                                                      • Dana-Farber to present more than 40 research studies at 2020 ASH Annual Meeting
                                                      • Dana-Farber to test blood cancer drug in COVID-19 patients
                                                      • Dana-Farber/Boston Children's named a top pediatric cancer program
                                                      • Dana-Farber/Brigham and Women’s Cancer Center and Stamford Hospital announce expanded collaboration
                                                      • Dana-Farber/Brigham and Women’s Cancer Center is ranked the best in New England
                                                      • Dana-Farber/Harvard Cancer Center wins prestigious federal grant to accelerate ovarian cancer research
                                                      • Donor stem cell transplant shown to improve survival in older patients with myelodysplastic syndrome
                                                      • Dozens of potential anti-cancer drugs netted in massive screening study
                                                      • Dozier Gardner Family Announces Gift to Establish Fund at Dana-Farber Cancer Institute
                                                      • Drug with new approach on impeding DNA repair shows promise in first clinical trial
                                                      • Genetic test identifies patients with invasive lobular breast cancer at high risk of disease recurrence
                                                      • Genomic test accurately identifies patients with smoldering multiple myeloma at high risk of developing myeloma, study finds
                                                      • Immune system changes occur early in development of multiple myeloma, study finds
                                                      • Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer
                                                      • Jeannie and Jonathan Lavine Establish the Lavine Family Fund for Preventative Cancer Therapies
                                                      • John Ryan named Senior Vice President and General Counsel at Dana-Farber Cancer Institute
                                                      • Kathleen McDaniel named Senior Vice President, Chief People Officer at Dana-Farber Cancer Institute
                                                      • Keeping cancer clinical research on track during a pandemic: A case study from Dana-Farber Cancer Institute
                                                      • Kimmie Ng, MD, MPH of the Young-Onset Colorectal Cancer Center Receives Colorectal Cancer Alliance Grant for Microbiome Research
                                                      • Lesley Solomon of Dana-Farber Cancer Institute receives an Extraordinary Women Advancing Healthcare award
                                                      • Local women leaders hear about revolutionary developments in women’s cancer research at Dana-Farber Cancer Institute
                                                      • Massive study reveals how “hypermutated” malignant brain tumors with many mutations escape chemotherapy and immunotherapy
                                                      • Medicaid expansion linked to lower mortality rates for three major types of cancer
                                                      • More than 110 Dana-Farber-affiliated physicians recognized as Top Doctors
                                                      • More than 30 research studies led by Dana-Farber faculty to be presented at San Antonio Breast Cancer Symposium
                                                      • Mortality rate after cancer surgery drops during 10-year period, but gap persists between Black and white patients
                                                      • MPM Capital Announces $100M Oncology Innovations Fund as Part of Novel Venture Philanthropy Collaboration with Dana-Farber Cancer Institute  
                                                      • Multinational study identifies high risk to cancer patients diagnosed with COVID-19
                                                      • National Academy of Inventors names Gordon Freeman a 2020 Fellow
                                                      • Native American ancestry associated with increased mutations in EGFR gene among Latin American patients with lung cancer
                                                      • New 3-D model of a DNA-regulating complex in human cells provides cancer clues
                                                      • New blood test can detect wide range of cancers, now available to at risk individuals in clinical study at Dana-Farber
                                                      • New map provides scientists with head start on how to destroy cancer-related enzymes rather than just block them
                                                      • New targeted agent produces considerable responses in trial with patients with uterine serous carcinoma
                                                      • New technique may quickly and accurately predict effective therapies in solid tumors
                                                      • Newsweek Names Dana-Farber #3 in the World for Cancer
                                                      • Novel targeted drug shows promise in advanced kidney cancer
                                                      • Online program significantly improves insomnia in adolescent and young adult cancer survivors, study finds
                                                      • Patient-partnered research finds clues about a rare cancer’s genetic roots
                                                      • Patients with multiple myeloma and CHIP often have worse outcomes following autologous stem cell transplant, study finds
                                                      • Personalized blood biopsies demonstrate potential as early-warning signal of breast cancer recurrence
                                                      • Phyllis F. Cantor Center for Research in Nursing and Patient Care Services awarded two major research grants
                                                      • Pre-operative immunotherapy shows promise in oral cancers
                                                      • Prostate cancer metastasis linked to revival of dormant molecular program
                                                      • Researchers describe recently discovered condition involving numerous gastrointestinal polyps in childhood cancer survivors
                                                      • Scientists identify factors for predicting which patients with ovarian cancer won’t benefit from immunotherapy-PARP inhibitor combination
                                                      • Scientists produce a reference map of human protein interactions, releasing data helpful for understanding diseases including cancer and infectious diseases such as COVID-19
                                                      • SHE Center at Dana-Farber and Silverberry Genomix form SHE Biobank, a population health initiative for research and education
                                                      • Six new members elected to the Board at Dana-Farber Cancer Institute
                                                      • Small Molecule Activator of Tumor-Suppressor Protein Kills T-Cell Acute Lymphoblastic Leukemia (T-ALL) Cells, Researchers Report
                                                      • Statement on U.S. Court of Appeals ruling regarding joint inventorship of six immnunotherapy patents
                                                      • Stuart Orkin named 2020 King Faisal Prize Laureate in Medicine
                                                      • Study offers global review of impact of COVID-19 on cancer treatment and research
                                                      • Study provides molecular look at how healthy muscle adapts to exercise
                                                      • Study reveals factors influencing outcomes in advanced kidney cancer treated with immunotherapy
                                                      • Study reveals surprising benefit of clonal hematopoiesis in allogeneic transplants
                                                      • Study shows comprehensive genomic profiling identified co-occurring alterations that may cause treatment resistance in patients with METex14-altered non-small cell lung cancer
                                                      • Study takes most comprehensive look to date at connection between the ancestry and the molecular makeup of cancer
                                                      • Targeted inhibitor of mutated KRAS gene shows promise in early trial for lung, bowel, and other solid tumors
                                                      • The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
                                                      • Three Dana-Farber faculty members elected as Fellows of The American Association for Cancer Research
                                                      • Three Dana-Farber physician scientists receive Doris Duke Charitable Foundation 2020 Clinical Scientist Development Awards
                                                      • Trial finds benefit of immunotherapy-chemotherapy combination in early-stage triple-negative breast cancer
                                                      • Two Dana-Farber faculty members elected as Fellows of the American Association for the Advancement of Science
                                                      • Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers
                                                    • 2021
                                                      • “45 is the new 50” as age for colorectal cancer screening is lowered
                                                      • A. Thomas Look, MD, awarded 2021 Society of Memorial Sloan Kettering Prize Recipient for Contributions in Pediatric Oncology
                                                      • Alan D’Andrea, MD elected to National Academy of Sciences
                                                      • Antibiotic Novobiocin found to kill tumor cells with DNA-repair glitch
                                                      • Antibody-drug conjugate shows impressive activity in patients with non-small cell lung cancer with mutation in HER2 gene
                                                      • Award aims to accelerate treatment options in metastatic prostate cancer
                                                      • Benefit of immunotherapy combination for patients with advanced melanoma extends to subsequent treatment, study finds
                                                      • Benjamin Ebert is the recipient of the 2021 Stanley J. Korsmeyer Award
                                                      • Break Through Cancer launches collaborative model across top U.S. research institutions in pursuit of cancer cures
                                                      • Bruce Spiegelman receives high honor from American Diabetes Association
                                                      • Cancer screenings rebounded in late 2020 after COVID-related decline, but racial and economic disparities remain for some tests
                                                      • CAR T-cell therapy generates lasting remissions in patients with multiple myeloma
                                                      • Caroline Powers named Senior Vice President for External Affairs
                                                      • Childhood Cancer Survivors, Providers Satisfied with Video Visits for Long-term Follow-up
                                                      • Christopher Lathan appointed Chief Clinical Access and Equity Officer at Dana-Farber
                                                      • Commonwealth Foundation for Cancer Research $25M gift to accelerate cancer research through collaboration of Dana-Farber/Harvard Cancer Center and Koch Institute for Integrative Cancer Research at MIT
                                                      • Count Me In Launches Metastatic Breast Cancer Project in Spanish/Count Me In Lanza el Metastatic Breast Cancer Project en español
                                                      • Count Me In opens to all patients with cancer across the United States and Canada
                                                      • Dana-Farber and Harvard Street Neighborhood Health Center to connect patients to cancer services
                                                      • Dana-Farber announces $4 million funding opportunity to improve community health by increasing access to services in Greater Boston
                                                      • Dana-Farber announces expanded joint research agreement with Novartis
                                                      • Dana-Farber announces initiatives for Colorectal Cancer Awareness month in March
                                                      • Dana-Farber awarding $4 million to improve community health through increased access to services in Greater Boston
                                                      • Dana-Farber Brigham Cancer Center is ranked the best in New England
                                                      • Dana-Farber Brigham Cancer Center launches new program for women with earliest form of breast cancer
                                                      • Dana-Farber Cancer Institute and Deerfield Management Launch Riverway Discoveries
                                                      • Dana-Farber Cancer Institute announces $2 billion fundraising campaign to Defy Cancer
                                                      • Dana-Farber Cancer Institute at the top of the 2021 Top 100 Women-Led Businesses in Massachusetts
                                                      • Dana-Farber Cancer Institute Establishes the David Liposarcoma Research Initiative
                                                      • Dana-Farber Cancer Institute faculty among world’s most highly cited researchers
                                                      • Dana-Farber Cancer Institute faculty recognized as 2021 ASCO leaders in cancer care
                                                      • Dana-Farber Cancer Institute launches investment fund to support startup companies
                                                      • Dana-Farber Cancer Institute opens new state-of-the-art location in Chestnut Hill
                                                      • Dana-Farber Cancer Institute receives the 2021 Community Hero Award presented by Make-A-Wish® Massachusetts and Rhode Island
                                                      • Dana-Farber joins Multi-Cancer Early Detection (MCED) Consortium to chart path forward for use of new technologies to improve early cancer detection
                                                      • Dana-Farber launches new podcast series, Unraveled
                                                      • Dana-Farber Medical Oncology Chair receives Sjöberg Prize for cancer research
                                                      • Dana-Farber new mobile mammography van debuts offering digital mobile breast cancer screening
                                                      • Dana-Farber nurses present research at 2021 Oncology Nursing Society Congress
                                                      • Dana-Farber research leads to better understanding of the immune system in kidney cancer
                                                      • Dana-Farber research supports FDA approval for immunotherapy combination in advanced kidney cancer
                                                      • Dana-Farber research supports FDA approval of immunotherapy drug given after surgery for certain patients with kidney cancer
                                                      • Dana-Farber researchers present key studies at ASCO annual meeting
                                                      • Dana-Farber researchers to present findings at San Antonio Breast Cancer Symposium
                                                      • Dana-Farber scientists team with British researchers to accelerate development of blood test for ovarian cancer
                                                      • Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine
                                                      • Dana-Farber to offer first CAR T-cell therapy for indolent follicular lymphoma following FDA approval
                                                      • Dana-Farber to present more than 30 research studies at 2021 ASH Annual Meeting
                                                      • Dana-Farber to present more than 30 research studies at the American Association for Cancer Research Annual Meeting 2021
                                                      • Dana-Farber to steward and grow Bright Pink’s robust suite of cancer prevention resources
                                                      • Dana-Farber, Broad Institute and Count Me In receive $16 million grant to launch patient-partnered research initiatives in rare cancers
                                                      • Dana-Farber/Boston Children's again named a top pediatric cancer program
                                                      • Dana-Farber/Boston Children’s Cancer and Blood Disorders Centers launches redesigned web site
                                                      • Dana-Farber’s Cigall Kadoch selected as a Howard Hughes Medical Institute Investigator
                                                      • Dana-Farber’s Judy Garber is recipient of Brinker Award for Scientific Distinction
                                                      • Discovery may lead to expanded donor pool for stem cell transplants for patients with cancer
                                                      • Donna Lee Ubertalli named a Top Hospital Marketer of the Year
                                                      • Drug combination found to keep chronic lymphocytic leukemia in young patients in remission for several years
                                                      • Expert panel issues recommendations for addressing cancer inequities
                                                      • FDA approval offers hope for prevention of acute graft-versus-host disease
                                                      • First FDA approval of CAR T-cell therapy for multiple myeloma marks milestone for patients
                                                      • First mammography screening guidelines issued for older survivors of breast cancer
                                                      • Five Dana-Farber Cancer Institute faculty members are inducted in the 2021 Giants of Cancer Care®
                                                      • For patients with multiple myeloma, vaccination offers protection from COVID-19, but less than other cancer patients receive
                                                      • For young patients with breast cancer, fertility concerns influence endocrine therapy decisions, study finds
                                                      • Genetic Signature of Tumor Cells Predicts Response to Chemotherapy Drug for Patients with Form of Ovarian Cancer
                                                      • George Demetri, MD elected as a Fellow of the American Association for Cancer Research (AACR) Academy
                                                      • Hale Family to Accelerate Pancreatic Cancer Research and Care with One of the Largest Single Gifts Ever to Dana-Farber Cancer Institute
                                                      • Healthy Neighborhoods Fund Gets Major Boost
                                                      • Heidi E. Conway joins Dana-Farber to lead Human Resources Department
                                                      • Immunotherapy – targeted drug combination improves survival in advanced kidney cancer
                                                      • Immunotherapy combination improves outcomes in advanced kidney cancer
                                                      • Immunotherapy combination shows benefit for patients with advanced melanoma, phase 3 trial shows
                                                      • Immunotherapy drug delays recurrence in kidney cancer patients
                                                      • Immunotherapy drug delays recurrence in kidney cancer patients(1)
                                                      • Immunotherapy may yield longer treatment-free survival than targeted therapy in advanced renal cell carcinoma patients
                                                      • In Memoriam: David Morse Livingston, MD, Renowned Scientist and Esteemed Mentor
                                                      • Laurie H. Glimcher, MD, named to Modern Healthcare’s Women Leaders Luminaries list
                                                      • Level of chromosomal abnormality in non-small cell lung cancer may predict response to immunotherapy
                                                      • Massachusetts Life Sciences Center funding to support a Metabolomics Facility at Dana-Farber
                                                      • Molecular analysis advances risk profiling and assessment of immunotherapy response in smoldering myeloma
                                                      • More than 110 Dana-Farber affiliated faculty named as 2021 Top Doctors in Boston Magazine
                                                      • New immunotherapy target discovered for malignant brain tumors
                                                      • New recommendations aim to eliminate racial bias in myeloma trials
                                                      • New research initiative launches for all patients ever diagnosed with colorectal cancer
                                                      • New research uncovers how cancers with common gene mutation develop resistance to targeted drugs
                                                      • New study finds link between patient survival and changes in tumor cell mass in brain cancer
                                                      • New study reveals elevated rates of blood cancer precursor condition in groups at high risk for multiple myeloma
                                                      • New study shows young women with breast cancer who opt for mastectomies report lower quality of life
                                                      • New targeted agent achieves impressive response rate in trial with patients with uterine serous carcinoma
                                                      • Newsweek names Dana-Farber #3 in the world for cancer
                                                      • On Lynch Syndrome Awareness Day, Dana-Farber encourages people to know their risk for common inherited condition that increases susceptibility to cancer
                                                      • Personalized vaccine produces long-lasting anti-tumor response in patients with melanoma, study shows
                                                      • Prostate cancer partnership honored for statistical excellence in accelerating therapeutic advances
                                                      • Red meat consumption may promote DNA damage-associated mutations in patients with colorectal cancer
                                                      • Scientists create ON-OFF switches to control CAR T cell activity
                                                      • Statement regarding U.S. Supreme Court action on patent lawsuit
                                                      • Stuart Orkin receives $500,000 Gruber Genetics Prize for his groundbreaking research on the genetics of inherited blood disorders
                                                      • Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation therapy
                                                      • Study finds new evidence of health threat from chemicals in marijuana and tobacco smoke
                                                      • Study finds signs of worsening pain management for patients with terminal cancer
                                                      • Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate
                                                      • Study shows sharp decline in cancer screenings and diagnoses during the first COVID-19 surge
                                                      • Study sounds note of caution on effectiveness of COVID-19 vaccines for patients with lymphoid malignancies
                                                      • Study underscores need for multidisciplinary care for COVID-19 long-haulers
                                                      • Survival benefits of immunotherapy combination persist for more than six years in patients with advanced melanoma
                                                      • Survival similar for younger and older patients with metastatic colorectal cancer, study finds
                                                      • Tamoxifen may boost PI3K signaling to increase uterine cancer risk in some patients
                                                      • Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors
                                                      • Targeted drug shows activity against brain metastases in kidney cancer
                                                      • Triplet therapy shows promise in phase 2 study in chronic lymphocytic leukemia
                                                      • Two Dana-Farber faculty elected to National Academy of Medicine
                                                      • Two Dana-Farber researchers receive prestigious New Innovator Award from the National Institutes of Health
                                                      • Venetoclax shown to benefit patients with Waldenström Macroglobulinemia, including some who relapsed after previous therapy
                                                      • Vitamin D may protect against young-onset colorectal cancer
                                                    • 2022
                                                      • Goldie Taylor named Senior Vice President, Chief Communications and Marketing Officer
                                                      • Immunotherapy combination shows significant benefit for patients with advanced melanoma
                                                      • Paula and Rodger Riney Foundation makes $40 million transformative grant to further multiple myeloma research at Dana-Farber Cancer Institute
                                                  • News Videos
                                                  • Publications
                                                    Make An Appointment
                                                    Maps & Directions
                                                    • About Dana-Farber
                                                    • Make an Appointment
                                                    • Find a Doctor
                                                    • How You Can Help
                                                    • Contact Us
                                                    • For Patients & Families
                                                    • Why Dana-Farber
                                                    • Care & Treatment
                                                    • Becoming a Patient
                                                    • Caring for a Loved One
                                                    • Prevention & Risk
                                                    • For Survivors
                                                    • My Dana-Farber
                                                    • Research
                                                    • Clinical Trials
                                                    • Departments Centers and Labs
                                                    • Core Facilities
                                                    • Innovations
                                                    • Featured Research
                                                    • Our Researchers
                                                    • For Physicians
                                                    • Refer a Patient
                                                    • Education & Training
                                                    • Clinical Resources
                                                    • Physician Gateway
                                                    • Newsroom
                                                    • Insight Blog
                                                    • Careers at Dana-Farber
                                                    • Health Library
                                                    • Events Calendar
                                                    • Español

                                                    Stay in touch with us

                                                    Recipes, discoveries, workshops, stories of hope and triumph can be found in the pages of Spotlight, Dana-Farber’s free digital newsletters.

                                                    Sign-Up
                                                    • Twitter
                                                    • Pinterest
                                                    • Facebook
                                                    • Linkedin
                                                    • Youtube
                                                    • Instagram
                                                    Harvard Medical School
                                                    Magnet Recognized
                                                    NCI
                                                    NCCN

                                                    Copyright 2022 Dana-Farber Cancer Institute
                                                    450 Brookline Avenue, Boston, MA 02215
                                                    Call us: 617-632-3000

                                                    • Privacy Policy
                                                    • Terms of Use
                                                    • Sitemap
                                                    Dana-Farber building